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AD  Alzheimer’s  disease 
aSMase acid Sphingomyelinase 
3-NP  3-Nitropropionic acid 
Bak  Bcl-2 antagonist killer 1 
Bax  Bcl-2 associated x protein 
Bcl-2  B-cell lymphoma 2 
Bcl-xL  B-cell lymphoma extra-large 
BH  Bcl-2 homology 
Bid  BH3-interacting domain death antagonist 
BSA  Bovine serum albumin 
CerS  Ceramide synthase 
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Cybrid  Cellular hybrid 
e-  Electron 
ER  Endoplasmic reticulum 
H  hours 
H2O2  Hydrogen peroxide 
IMM  Inner mitochondrial membrane 
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DMSO  Dimethyl sulfoxide 
DKO  Double knockout 
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MOMP  Mitochondrial outer membrane permeabilization 
mtDNA  mitochondrial DNA 
nDNA  nuclear DNA 
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OMM  Outer mitochondrial membrane 
ON  Over night 
OXPHOS Oxidative phosphorylation 
O2-  Superoxide anion 
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PD  Parkinson’s  disease 
ROS  Reactive oxygen species 
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RT  Room temperature 
SDS  Sodium dodecyl sulfate 
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WB  Western blot 
 
  Abstract 
  V 
Abstract 
Apoptosis, the physiological cell death, is an essential component of cellular homeostasis and 
tissue regeneration, and the dysregulation of apoptosis culminates in multiple human diseases. 
Whereas the failure to execute timely programmed cell death in renovating tissues contributes 
to cancer, excessive apoptosis in post-mitotic tissues precipitates degenerative states, aging and 
aging-associated diseases. 
Research work within the last two decades has shown that tissue degeneration caused by 
mitochondrial oxidative phosphorylation (OXPHOS) defects is associated with excessive 
apoptosis. However, it is unclear how OXPHOS-dysfunctions interfere with the apoptotic 
machinery and how this impacts on tissue degeneration. 
In this context we demonstrate that solely the chemical induction of cytochrome c oxidase 
(COX) deficiency, which is among the most common defects found in mitochondrial diseases, 
exclusively and dramatically increases the Bcl-2 dependent apoptotic response towards oxidative 
stress. Furthermore, we could widen and reconfirm our findings in COX-deficient cybrids 
harboring an mtDNA-encoded deletion of COX subunit I as well as in murine fibroblast devoid of 
COX-assembly factor COX10. These findings indicate a general mechanism of COX-deficiency 
induced apoptosis by oxidative stress. Moreover, our data highlight that COX-deficiency is 
accompanied by an increased de novo synthesis and accumulation of the sphingolipid species 
ceramide. Due to their chemical properties especially ceramides with an acyl side-chain length of 
C16:0 have conclusively and repeatedly been demonstrated to induce apoptosis by pore-
formation and by contributing to pro-apoptotic Bax and Bak induced permeabilization of the 
mitochondrial outer membrane (MOMP). Correspondingly, we show that the inhibition of 
endoplasmic reticulum-resident specific ceramide synthases abrogates enhanced apoptosis 
induced by mitochondrial respiratory chain-dysfunction. In particular, we identify ceramide 
synthase 6 (CerS6) as the key mediator of C16:0 ceramide induced apoptosis to oxidative stress: 
While down-regulation of CerS6 protects COX-deficient cells from oxidative stress, 
overexpression of CerS6 introduces susceptibility towards oxidative stress in COX-functional 
cells. 
In summary, our findings identify ceramide accumulation and in particular CerS6 as important 
components of the apoptotic response of COX-deficient cells towards oxidative stress and 
provide new insights into how mitochondrial dysfunction interferes with the apoptotic machinery 
and may impact on tissue homeostasis. 
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Zusammenfassung 
Apoptose, besser bekannt als physiologischer Zelltod, ist ein wichtiger Bestandteil der Zell-
Homöostase sowie der Geweberegeneration. Ein Ungleichgewicht im physiologischen Zelltod 
kann die Entstehung multipler Krankheiten beim Menschen begünstigen. So ist beispielsweise 
eine verminderte oder gänzlich reduzierte Apoptose ursächlich für die Entstehung von Krebs, 
wohingegen exzessive und deregulierte Apoptose in postmitotischen Gewebe zu degenerativen 
Krankheiten bzw. altersbedingten Krankheitserscheinungen führen kann. 
Die Forschungsarbeit der letzten zwei Jahrzehnte hat aufgezeigt, dass die Gewebedegeneration 
aufgrund defekter mitochondrialer oxidativer Phosphorylierung (OXPHOS) mit erhöhter Apoptose 
assoziiert ist. Hierbei ist jedoch unklar, wie genau sich Störungen der OXPHOS auf den 
Wirkungsmechanismus der Apoptose auswirken und wie dies dann zur Gewebedegeneration 
beiträgt. 
In diesem Zusammenhang können wir zeigen, dass ausschließlich der durch chemische 
Inhibition hervorgerufene Defekt der Cytochrome C Oxidase (COX), eine der am häufigsten 
auftretenden Defekte bei mitochondrialen Erkrankungen, ursächlich für eine erhöhte Bcl-2 
abhängige Apoptose aufgrund von oxidativem Stress ist. Diese Befunde konnten durch weitere 
Untersuchungen in einer COX-defizienten Cybridlinie, welche einen mitochondrial-kodierten 
Defekt der strukturellen COX-Untereinheit I enthält, sowie in murinen Knockout-Fibroblasten des 
Assembly-Faktors COX10 bestätigt und untermauert werden. Unsere Untersuchungen deuten 
daher auf einen generellen Wirkungsmechanismus der durch COX-Defizienz induzierten 
Apoptose nach oxidativem Stress hin. 
Des Weiteren belegen unsere Untersuchungen, dass Defekte der COX mit einer erhöhten de 
novo Synthese und der Anhäufung von Ceramiden einhergehen. Für Ceramide, insbesondere 
solcher mit einer C16:0 Seitenkette, konnte in der Vergangenheit wiederholt gezeigt werden, dass 
sie bei der Permeabilisierung der äußeren mitochondrialen Membran (engl. MOMP) mittels der 
pro-apoptotischen Proteine Bax und Bak eine wichtige Funktion als Porenbildner einnehmen. In 
diesem Zusammenhang zeigt die hier vorliegende Arbeit, dass die durch oxidativen Stress  
hervorgerufene Apoptose in COX-defizienten Zellen durch die Blockade der sich am 
endoplasmatischen Retikulum befindenden Ceramide-Synthasen vollständig aufgehoben werden 
kann. Insbesondere können wir hierbei zeigen, dass die Ceramide-Synthase 6 (CerS6) eine 
Schlüsselrolle in der Apoptose von COX-defizienten Zellen auf oxidativen Stress einnimmt:
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Während eine Verminderung der CerS6-Expression in COX-defizienten Zellen vor oxidativem 
Stress schützt, bewirkt die Überexpression von der CerS6, dass normal respirierende Zellen ohne 
COX-Defekt gegenüber oxidativem Stress anfällig werden. 
Zusammenfassend zeigt die vorliegende Arbeit, dass die Akkumulation von Ceramiden sowie die 
CerS6 essentielle Bestandteile der durch oxidativen Stress-induzierten Apoptose in Zellen mit 
defekter COX sind. Unsere Arbeit ermöglicht neue Einblicke in die Auswirkungen von 
mitochondrialen Defekten auf den Prozess des physiologischen Zelltods und wie sich dies auf die 
Gewebe-Homöostase auswirken könnte. 
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Introduction 
Apoptosis, the controlled demolition of a cell 
The indispensable physiological process of programmed cell death was first described by Kerr, 
Wyllie and Currie around forty years ago (Kerr et al., 1972). Based on its characteristic 
morphological changes including chromatin condensation, fragmentation of the nucleus, 
organelle degradation as well as cell shrinkage and blebbing it was termed apoptosis, referring 
to   the  Greek   term   for   “dropping  off”   petals   from   flowers (Williams et al., 1974; Wyllie et al., 
1980). The result of these morphological changes is the formation of cellular fragments termed 
apoptotic bodies which are finally cleared by phagocytes, preventing damage to the surrounding 
tissue by uncontrolled spilling of cellular debris and allowing the recovery of precious cellular 
constituents (Reddien et al., 2001; Ravichandran & Lorenz, 2007). These processes are mainly, 
but not exclusively, orchestrated by members of a family of cysteine proteases known as 
caspases. Caspases cleave their substrates after specific aspartate   residues   (the   “asp”   in   the 
word caspase), while the hydrolysis of the peptide bond is catalyzed by a cysteine in the active 
site (the   “c”   in   the word caspase) (Yuan et al., 1993; Nicholson & Thornberry, 1997). The 
activation of caspases occurs via two major pathways, referred to as extrinsic and intrinsic 
pathway of apoptosis (Figure 1.1). 
The extrinsic pathway of apoptosis is activated by the binding of extracellular death ligands of 
the tumor necrosis factor (TNF) family such as FAS-ligand, TNF- or TRAIL to death receptors 
on the surface of the plasma membrane. Ligand-binding provokes receptor oligomerization and 
the recruitment of adapter proteins like FAS associated death domain (FADD), which in turn 
recruits the initiator caspase 8 to form the death inducing signaling complex (DISC) (Kischkel et 
al., 1995; Boatright et al., 2003). Caspase 8 becomes activated and then directly cleaves and 
activates the downstream executioner caspases 3 and 7 which conduct protein degradation and 
apoptosis. 
The intrinsic pathway of apoptosis can be initiated cell-autonomously by overwhelming 
intracellular stress such as DNA damage, viral infection or growth factor withdrawal. Because 
intrinsic apoptosis arises from the mitochondrial outer membrane permeabilization (MOMP) 
followed by the release of pro-apoptotic intermembrane space (IMS) proteins like cytochrome c 
into the cytosol, it is also referred to as the mitochondrial pathway of apoptosis. The release of 
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cytochrome c into the cytosol stimulates the ATP-dependent oligomerization with apoptotic 
protease activating factor 1 (APAF1) to form the apoptosome, which in turn catalyzes the auto-
activation of initiator caspase 9 (Liu et al., 1996; Li et al., 1997). Activated caspase 9, like 
caspase 8, then directly cleaves and activates executioner caspases. Both pathways are 
interconnected by the capability of caspase 8 to proteolytically activate Bid, a BH3-only member 
of the Bcl-2 protein family, which upon truncation (then called tBid) translocates to mitochondria 
and initiates MOMP (Figure 1.1). 
 
 
 
Figure 1.1 | Extrinsic and intrinsic pathway of apoptosis 
Upon binding of a death ligand to its specific receptor on the surface of the plasma membrane, the DISC 
complex constitutes and initiator caspase 8 becomes activated. Caspase 8 either directly activates 
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executioner caspases 3/7 or indirectly by cleaving BH3-only protein Bid. tBid activates pro-apoptotic 
Bax/Bak on the outer mitochondrial membrane while activation of Bax/Bak is antagonized by anti- 
apoptotic Bcl-2 proteins. Bax/Bak induce MOMP, resulting in the release of IMS proteins like cytochrome c 
and activation of initiator caspase 9. In turn caspase 9 cleaves and activates caspase 3/7, thereby 
executing the apoptotic demise of the cell. PM, plasma membrane; Cyt c, cytochrome c.  
Point of no return: Mitochondrial outer membrane permeabilization 
MOMP is considered as the point of no return, making it profoundly important to provide well-
balanced regulatory mechanisms which are carried out by proteins of the B- cell lymphoma 2 
(Bcl-2) family. Based on their role in conducting apoptosis, Bcl-2 proteins are subdivided into 
three classes: the class of pro-apoptotic Bcl-2 proteins like Bax and Bak which are responsible 
for MOMP, the class of anti-apoptotic Bcl-2 proteins such as Bcl-2, Bcl-xL and Mcl-1 which 
counteract MOMP by directly binding and inhibiting Bax or Bak, and the divergent class of BH3-
only proteins including Bad, Bik, Bid, Bim, Bmf, Noxa and Puma that can bind and regulate the 
activity of pro- and anti-apoptotic Bcl-2 proteins likewise. Recent evidence suggests that BH3-
only proteins de-repress and liberate Bax and Bak by direct binding and inhibition of anti-
apoptotic family members (Westphal et al., 2014). By contrast, an opposing model postulates 
direct activation of Bax and Bak by BH3-only proteins including Bim, tBid and Puma (Tait & 
Green 2010).  
The mitochondrial apoptotic pathway depends on the activation of Bax and Bak, either of which 
is sufficient to drive MOMP in the majority of cells. Upon cytotoxic stress, the hydrophobic BH3-
domain of Bax and Bak becomes exposed and facilitates the generation of stable homo-
oligomers that insert into the outer mitochondrial membrane, forms membrane pores and 
thereby provokes the release of pro-apoptotic IMS-proteins (Zha et al., 1996; Dewson et al., 
2008; Kim et al., 2009). The insertion of Bax and Bak into the outer mitochondrial membrane 
represents a central prerequisite for their pro-apoptotic action which is directed by a C-terminal 
tail anchor (TA). The tail anchor potentiates the association of cellular proteins mainly with 
mitochondria or the endoplasmic reticulum (ER), where they are inserted into the lipid 
membrane via a single membrane span. Pro-apoptotic Bak resides as an inactive monomer in 
the outer mitochondrial membrane where it is constantly bound and inactivated by anti-
apoptotic Mcl-1 and Bcl-xL (Willis et al. 2005). Unlike Bak and the majority of TA-proteins, 
including the anti-apoptotic Bcl-2 family members Bcl-2 and Bcl-xL that are constitutively bound 
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to their target membranes, Bax in its monomeric inactive state predominantly appears in the 
cytosol and translocates to the mitochondria upon activation (Hsu & Youle 1998). Whereas only 
a minor fraction of Bax has been shown to be loosely attached to the outer mitochondrial 
membrane, the solubility of Bax is effectively regulated by the reduced exposure of its 
hydrophobic C terminus (Suzuki et al., 2000). Recent data conclusively demonstrated that Bax 
exists in a dynamic equilibrium between the cytosolic and mitochondrial compartment and that 
the subcellular localization of Bax is constantly maintained by Bcl-xL (Schellenberg et al. 2013; 
Edlich et al. 2011).  
Previous work revealed that the pore formation in the outer mitochondrial membrane is not only 
controlled by the expression status of Bcl-2 protein family members, but that in addition the lipid 
composition of the mitochondrial outer membrane is also critical for the action of Bcl-2 proteins. 
The vast majority of membrane phospholipids and lipid precursors are synthesized in the ER and 
are delivered via vesicle transport or lipid-transfer proteins (LTP) for further processing into the 
Golgi apparatus, peroxisomes and mitochondria (Lev 2012). Initial studies performed on 
unilamellar vesicles mimicking outer mitochondrial membranes provided conceptional advances 
concerning the interplay of Bcl-2 proteins and mitochondrial lipids. Further work has 
demonstrated that the embedment of pro-apoptotic Bax together with tBid (Lovell et al. 2008; 
Shamas-Din et al. 2013) as well as anti-apoptotic Bcl-xL (Billen et al., 2008) into membrane 
compartments mimicking the outer mitochondrial membrane is necessary for the regulation of 
Bax. 
The inner and outer mitochondrial membranes are predominantly composed by the two 
phospholipids phosphatidylcholine (PC) and phosphatidylethanolamine (PE), representing 
approximately 70-80% of the total mitochondrial membrane lipid content. Phosphatidylinositol 
(PI) and the diglycerophospholipid cardiolipin (CL) account for 10-15%, while other 
phospholipids including sphingomyelins are only detectable in trace amounts (Horvath & Daum, 
2013). CL is unique among the mitochondrial phospholipids in that it is mitochondria-exclusive 
and mainly resides in the inner mitochondrial membrane. Beside its function in membrane 
fluidity, supercomplex assembly and stability (Pfeiffer et al. 2003), CL has been demonstrated to 
be essential for tBid mediated Bax oligomerization and pore formation in liposomes (Lutter et 
al., 2000; Kuwana et al., 2002) and early oxidation of CL in apoptosis is critical for the 
dissociation of cytochrome c from the inner mitochondrial membrane and release into the 
cytosol (Kagan et al., 2005; Choi et al., 2007). Accordingly, overexpression of phospholipid 
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scramblase 3 (PLS3), a mitochondrial flippase responsible for the transfer of CL between inner 
and outer mitochondrial membrane compartments, increased CL exposure on the mitochondrial 
surface and enhanced mitochondrial apoptosis upon TNF- treatment (Liu et al., 2008). 
Furthermore, perturbation of CL biosynthesis is sufficient to sensitize mitochondria to both 
extrinsic and intrinsic apoptotic stress (Potting et al. 2013). 
In addition to CL, distinct sphingolipids species have been shown not only to be involved in 
membrane architecture, but also in numerous and diverse cellular processes such as 
proliferation, differentiation, senescence, inflammation as well as in the induction and inhibition 
of apoptosis (Hannun & Obeid 2008). In this regard, ceramides have become the center of 
attention since the early discoveries of the molecular principles of apoptosis (Obeid et al., 1993) 
and the pivotal function of ceramides in mediating apoptosis has been intensely described 
(Tirodkar & Voelkel-Johnson 2012; Chipuk et al. 2012). The vast majority of mammalian 
sphingolipids have a C18:0 sphingoid base linked to a varying side chain, whereas the head group 
is either unmodified (ceramides), contains a phosphocholine group derived from 
phosphatidylcholine (sphingomyelins) or is linked to mono- or oligosaccharides (cerebrosides 
and gangliosides, respectively). Ceramides exert their physiological role in a fatty acyl side-chain 
specific manner. Here, especially ceramides containing a C16:0 side chain have been shown to 
participate in Bax/Bak dependent MOMP by versatile stress stimuli including death ligand binding 
(Matsko et al., 2001), UV light (Kashkar et al., 2005) and irradiation (Lee et al. 2011), though 
the exact biochemical nature of the interplay between ceramides and Bcl-2 proteins in pore 
formation remains controversial (discussed in Renault & Chipuk, 2014). 
Dysregulation of apoptosis 
In order to maintain the cellular orchestra of constant renovation and demise, multicellular 
organisms are not only highly dependent on accurate regeneration and replacement of cells, but 
also on their controlled degradation. Therefore, the prerequisite of tissue homeostasis is that if 
cells are constantly renewed, an equal amount must necessarily die. Initial experiments in the 
model organism Caenorhabditis elegans illustrated the critical role of apoptosis in the 
embryogenesis and development of organisms (Ellis & Horvitz 1986). Similar observations in 
flies and vertebrates like zebrafish and rodents underscored the fundamental role of apoptosis in 
embryogenesis and development. For example, pro-apoptotic Bax and Bak were shown to be 
crucial for embryonic development in mice, given that the majority of double knockout animals 
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die prenatally or display multiple developmental defects (Lindsten et al. 2000). Additionally, the 
generation of caspase knockout mice further underlined the importance of effective apoptosis in 
embryogenesis and development, revealing prenatal mortality or neurological defects in 
adulthood in caspase 3, 8 and 9 knockout mice (reviewed in Kumar, 2007). In addition to its 
involvement in embryonic development, imbalanced apoptosis in adult tissues may cause 
defects in tissue homeostasis and prelude the progression of numerous different diseases. 
Accordingly, failure to precisely execute timely controlled cell death in renovating tissues 
contributes to the formation of cancer. On the other hand, excessive programmed cell death 
particularly in post-mitotic tissue is assumed to precipitate degenerative states and is implicated 
in the progression of aging and aging associated diseases like Alzheimer’s   disease   and  
Parkinson. 
Inhibition of Apoptosis and cancer 
There is a general consensus that the transformation of healthy cells into tumorigenic and 
malignant cells is characterized by the acquisition of eight biological capabilities in a multistep 
process caused by genomic instabilities: 1.) Reprogramming of energy metabolism, 2.) escaping 
immune response, 3.) sustaining proliferative signaling and 4.) evading growth suppressors, 5.) 
inducing angiogenesis, 6.) activating invasion and metastasis, 7.) enabling replicative 
immortality and 8.) resisting cell death (Hanahan & Weinberg 2011). The importance of 
apoptosis and the implications of its alteration in the progression of different malignancies has 
accompanied the advances made in understanding the molecular mechanism, regulation and 
physiological role of apoptosis ever since (Evan & Littlewood 1998). Indeed, already in the initial 
work done by Kerr and coworkers, apoptosis was correlated to therapeutically induced tumor 
regression (Kerr et al. 1972). Accordingly, apoptosis reduction in cancer progression and 
maintenance can be associated with defective death receptor signaling, dysregulated caspase 
activation and misbalances in the interaction of pro- and anti-apoptotic Bcl-2 proteins. Here, 
overexpression of anti-apoptotic Bcl-2 proteins like Bcl-2, Mcl1 and Bcl-xL and transcriptional 
and/or post-transcriptional repression of pro-apoptotic Bcl-2 members like Bax and Bak and 
BH3-only proteins have been demonstrated as iterant traits of cancer cells (Beroukhim et al. 
2010; Kelly & Strasser 2011). On the basis of these findings, enormous efforts have been made 
in utilizing pro-apoptotic compounds targeting anti-apoptotic Bcl-2 proteins in the hope to 
reintroduce the apoptotic potential in tumors and tumor environments (Lessene et al., 2008). In 
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this context, therapeutic strategies have already entered the clinical application with great 
promise in treating patients suffering hematologic malignancies (Brinkmann & Kashkar 2014). 
Increased apoptosis and degenerative diseases 
Unopposed or increased apoptosis is considered as a cause of tissue degeneration in aging and 
aging-associated diseases. In particular, increased apoptosis and the alterations of neuronal 
tissues such as Alzheimer’s and Parkinson’s disease are well described. Alzheimer’s  disease (AD) 
is the most common neurodegenerative disease, characterized by the progressive decline of 
neurons and synapses in the cerebral cortex and subcortical regions. AD is described by the 
accumulation of amyloid-ß peptide deposits in extracellular plaques and hyperphosphorylation of 
the microtubule-associated protein tau, eventually leading to the degeneration of affected 
regions. Apoptosis has been shown to be essential for the onset of the disease, especially in the 
caspase-mediated proteolysis of the amyloid precursor protein (APP) resulting in the 
aggregation of amyloid-ß peptides (Gervais et al., 1999; Garwood et al., 2011). Furthermore, 
Rohn and colleagues could demonstrate that by inhibiting apoptosis through overexpression of 
anti-apoptotic Bcl-2 in a mouse model of AD, the pathology could be drastically reduced (Rohn 
et al. 2008). 
Parkinson’s   disease (PD) is the second most prevalent neurodegenerative disease and is 
characterized by a loss of specific dopaminergic neurons of the substantia nigra. PD has been 
linked to mutations in several genes necessary for efficient autophagic recovery of defective 
mitochondria and apoptosis regulation such as parkin and (PTEN)-induced kinase 1 (PINK1) 
(Kitada et al., 1998; Valente et al., 2004). The E3-ligase parkin is involved in the ubiquitination 
and degradation of Bax and other pro-apoptotic proteins and hence acts as an anti-apoptotic 
sensitizer at the mitochondria, while PINK1 was shown to be necessary for the recruitment of 
parkin to mitochondria. PINK1 and parkin deletion were reported to enhance the levels of Bax 
translocation to the mitochondria and release of cytochrome c in the cytoplasm, resulting in 
constitutively elevated levels of active caspases (Wood-Kaczmar et al. 2008). 
In addition to AD and PD, degenerative diseases caused by mitochondrial oxidative 
phosphorylation (OXPHOS) defects are also assumed to be associated with elevated apoptosis 
primarily in affected tissues with high energy demands (Breuer et al. 2013). In this context, 
mutations in nuclear DNA (nDNA) as well as mitochondrial DNA (mtDNA) encoding factors 
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involved in the respiratory chain are known to be causative in versatile severe degenerative 
states, premature aging phenotypes and premature mortality (Ylikallio & Suomalainen 2012). 
These findings highlight the role of mitochondrial integrity in the formation of degenerative 
states and raised attention to the impact of mitochondrial respiratory chain defects in the onset 
of a vast range of degenerative diseases.  
The mitochondrial respiratory chain 
According to the chemiosmotic theory proposed by Peter Mitchell in 1961, the demand for 
energy in form of ATP by cells and whole organisms is predominantly achieved by the 
translation of energy from energetic molecules by a concerted transfer of electrons (e-) across 
an impermeable membrane, generating a chemical gradient which propels the synthesis of ATP 
(Mitchell 1961). This highly conserved process, termed oxidative phosphorylation, is located to 
the inner mitochondrial membrane (IMM) and composed of five large intermembrane complexes 
as well as the electron carriers ubiquinone and the inner membrane associated cytochrome c 
(Figure 1.2).  
 
        
Figure 1.2 | Mitochondrial electron transport chain and oxidative phosphorylation 
ATP production at the inner mitochondrial membrane (IMM) is coupled to the oxidation of nicotinamide 
adenine dinucleotide (NADH) at NADH-dehydrogenase (complex I) and flavin adenine dinucleotide 
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(FADH2) at Succinate dehydrogenase (complex II).  Electrons (e-) from complex I and II are transferred 
via reduction of ubiquinone (Q), which is then oxidized by Cytochrome c reductase (complex III). e- are 
transferred to Cytochrome c oxidase (complex IV) by consecutive reduction and oxidation of cytochrome c 
(C) and finally reduce molecular oxygen and protons to water at the matrix-side of complex IV. The 
energy released during the electron transfer drives the translocation of protons from the matrix to the 
intermembrane space (IMS) across complex I, III and IV, generating a membrane potential across the 
IMM which drives the generation of ATP at the ATP synthase (complex V) by reflux of protons into the 
mitochondrial matrix. Electric potential differences are depicted at several steps of the respiratory chain. 
Pi, inorganic phosphate  
The initial step of the oxidative phosphorylation cascade is the oxidation of the tricarboxylic acid 
cycle (TCA) metabolite nicotinamide adenine dinucleotide (NADH) by NADH-dehydrogenase 
(also referred to as complex I) (Hatefi & Stempel, 1969; Efremov et al., 2010; Hunte et al., 
2010). Oxidation of NADH is the result of a higher redox-potential of the matrix-faced prosthetic 
group flavin mononucleotide (FMN), and transfer of two e- to ubiquinone (or coenzyme Q10) is 
accompanied by a still controversial mechanism of proton translocation across the IMM 
(reviewed in Brandt et al., 2003). A second entry point into the electron transport chain is 
provided by succinate-dehydrogenase (complex II) at which succinate is oxidized to fumarate by 
the prosthetic group flavin adenine dinucleotide (FAD) and e- are subsequently transferred to 
ubiquinone by iron-sulfur clusters (Coles et al. 1979; Sun et al. 2005). Reduced ubiquinone is 
then oxidized by iron clusters within the heme group of cytochromes of cytochrome c reductase 
(complex III) (Hatefi et al., 1962; Xia et al., 1997), resulting in the dislocation of protons from 
the matrix side to the IMS and the transfer of e- to cytochrome c (Leung & Hinkle 1975). In the 
last step, cytochrome c is reoxidized by cytochrome c oxidase (complex IV), repeatedly leading 
to the translocation of protons and finalizing the e- cascade by the reduction of molecular 
oxygen and protons to water (Wikström, 1977; Tsukihara et al., 1996). As a result, the 
transformation of the electric potential of high-energetic metabolites originating from glycolysis, 
fatty acid oxidation and protein degradation generates a chemical gradient across the IMM 
known as proton motive force (PMF). This chemical gradient provokes a passive reflux of 
protons through the transmembrane channel of the FO subunit of the ATP-synthase (complex V) 
(Soper et al., 1979; Ogawa & Lee, 1984), thus powering alternating conformational changes in 
the F1 subunit of ATP-synthase and ultimately generating ATP from ADP and inorganic 
phosphate (Watt et al., 2010). 
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The mitochondrial respiratory chain and degenerative diseases 
Mitochondria resemble their bacterial ancestry in terms of size, membrane architecture and 
dynamics. Most importantly, during their endosymbiotic evolution, intense expansive and 
reductive rearrangement of the mitochondrial proteome and massive transfer of the 
mitochondrial genome to the nucleus has left the mitochondrial network with traces of mtDNA 
(Nass & Nass, 1963; Clayton & Vinograd, 1967), which encode indispensable structural subunits 
of all OXPHOS complexes, except for complex II, as well as tRNAs and ribosomal RNAs 
(Anderson et al. 1981). In contrast to OXPHOS-defects resulting from mutations of nuclear 
encoded structural subunits and assembly factors or by autosomal mutations in nuclear encoded 
genes responsible for mtDNA maintenance, mitochondrial disorders resulting from sporadic or 
maternally inherited mutations of the mtDNA are always the result of threshold effects, given 
that the copy number of mtDNA varies between hundreds or thousands within a single cell 
(Elliott et al., 2008). While both, autosomal or x-linked nDNA and maternally inherited mtDNA 
mutations can manifest degenerative diseases at any age, the onset of age-associated diseases 
is predominantly the consequence of accumulated mutations or deletions of mtDNA within the 
lifetime of organisms (Lin et al., 2002; Kraytsberg et al., 2006). 
Since the first descriptions of the molecular basis of disease-causing mutations of nuclear 
(Bourgeron et al., 1995) and mtDNA (Holt et al., 1988; Wallace et al., 1988) encoded OXPHOS 
proteins, the knowledge of degenerative diseases caused by mitochondrial dysfunction has 
widely expanded and to date more than 150 distinct genetic mitochondrial syndromes caused by 
approx. 300 mutations are known (Schon et al., 2012; Vafai & Mootha, 2012; 
www.mitomap.org/MITOMAP). The complex and diverse clinical appearance of distinct genetic 
mutations of OXPHOS complexes together with the bipartite origin of OXPHOS subunits has long 
time puzzled the understanding of mitochondrial disorders. Enormous advantages in molecular 
and cellular techniques like the standardized analysis of mtDNA mutations using cellular hybrids 
(cybrids) (King & Attardi 1989), the development of mouse models of nuclear encoded OXPHOS 
subunits and assembly factors (Vempati et al., 2009) and huge progress in genetic screenings 
have contributed to our current understanding of degenerative diseases (Ylikallio & Suomalainen 
2012). The currently known mtDNA and nDNA encoded disease-causing structural subunits and 
assembly factor are summarized in Table 1.1. 
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Table 1.1: Common disease-encoding OXPHOS genes either encoding structural 
subunits (mtDNA and nDNA) or assembly factors (nDNA only) of the respective 
OXPHOS Complexes (not included: mutations in mitochondrial tRNAs and rRNAs). 
Complex Genetic defect Genes 
I 
mtDNA ND1-ND6 
nDNA structural gene NDUFS1-NDUFS8; NDUFV1, 2; 
NDUFA1,2,11 
nDNA assembly factor NDUFAF1,2; C6orf66;C8ORF38 
II 
nDNA structural gene SDHA,SDHB,SDHC,SDHD 
nDNA assembly factor SDHAF1,2 
III 
mtDNA CYTB 
nDNA structural gene UQCRB,UQCRQ 
nDNA assembly factor BCS1L, TTG19 
IV 
mtDNA COX1-3 
nDNA structural gene COX6B1, COX4I2 
nDNA assembly factor SURF1, SCO1 & 2, COX10, 
COX15, C2orf64 
V 
mtDNA ATP6 & 8 
nDNA structural gene ATP5E 
nDNA assembly factor ATP12, TMEM70 
 
Most OXPHOS defects are the result of nDNA mutations, given that the vast majority of OXPHOS 
complexes and assembly factors are encoded by the nucleus. Accordingly, defects in complex I, 
by far the largest of all OXPHOS complexes, represent most of the known OXPHOS defects 
(reviewed in Zhu et al., 2009). Mutations in nDNA and in mtDNA encoded OXPHOS subunits as 
well as in mitochondrial tRNAs and rRNAs precipitate many different and often fatal 
degenerative states like, amongst others, myopathy, cardiomyopathy, encephalopathy, 
hepatopathy and stroke (reviewed in Breuer et al., 2013). In spite of the diversity of OXPHOS 
defects-derived syndromes, most frequent and common to all OXPHOS complexes, especially 
complex I and IV, is Leigh’s syndrome (LS) (Leigh 1951), a disease which is associated with 
lactic acidosis, muscle atrophy as well as bilateral, focal lesions of the basal ganglia and the 
brain-stem and early mortality (Baertling et al. 2014). French Canadian Leigh syndrome (LSFC), 
a type of LS frequently found in the region of Quebec and characterized by complex IV 
deficiency, is caused by mutations in the mitochondrial mRNA stability protein leucine-rich 
pentatricopeptide repeat motif-containing (LRPPRC) (Mootha et al., 2003; Debray et al., 2011). 
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Leber’s   hereditary   optic   neuropathy (LHON), a disease characterized by the degeneration of 
retinal ganglion cells, optic atrophy and loss of sight is the result of specific mtDNA mutations 
affecting complex I and, to lesser extent, complex III (Wallace et al., 1988; Bénit et al., 2009). 
Another disease shared by diverse mtDNA mutations is mitochondrial encephalomyopathy, lactic 
acidosis and stroke-like episodes (MELAS), a multisystem disorder affecting versatile tissues 
such as brain, muscle, heart and the endocrine system (Pavlakis et al., 1984) and mainly arises 
from a distinct mutation (“A3243G”)  in the mitochondrial tRNALeu (Majamaa et al. 1998) as well 
as from mutations in complex I (Dimauro & Davidzon 2005) and mtDNA encoded subunits of 
complex IV (Manfredi et al., 1995; Rossmanith et al., 2008). 
Degenerative diseases can also be the result of large scale deletions of mtDNA, first 
documented in patients suffering from Kearns-Sayre syndrome (KSS) by Moraes and colleagues 
in the early 1990s (Moraes et al., 1991; Moraes et al., 1992). More recent studies identified 
defects in proteins responsible for maintaining the mitochondrial nucleotide pool (Nishino et al., 
1999), nucleotide transport (Kaukonen et al., 2000), and DNA replication (Spelbrink et al., 2001; 
Van Goethem et al., 2001) respectively, as source for large mtDNA deletions. 
The mitochondrial respiratory chain and cell death 
Within the last two decades, advantages in molecular techniques tremendously supported our 
understanding of the clinical features of degenerative diseases caused by defective OXPHOS and 
it became evident that tissue degeneration is associated with enhanced cell death. In LS, tissue 
degeneration mainly arises from necrotic cell death, though several investigations have linked 
the loss of cerebral tissue to enhanced apoptosis both histochemically (Formichi et al., 2004) or 
in cultured cybrids (Carrozzo et al. 2004), while a shift from apoptosis to necroptosis has also 
been reported (Quintana et al., 2010). Apoptotic cell death was also detected in peripheral blood 
lymphocytes of patients with LHON (Battisti et al. 2004), in cybrids containing different mtDNA 
mutations encoding complex I subunits ND1, 4 and 6 (Danielson et al. 2002; Ghelli et al. 2003), 
in patients suffering from KSS, MELAS and chronic progressive external ophthalmoplegia (CPEO) 
(Mirabella et al., 2000; Auré et al., 2006) and in patients with complex IV deficiency (Di 
Giovanni et al. 2001). Chemical inhibition of complex I in mice and utilizing complex I deficient 
cybrids revealed oxidative damage induced cell death, presumably by sensitizing affected cells to 
Bax-induced apoptosis (Perier et al. 2005). In addition, skin fibroblasts from patients suffering 
from complex V deficiency derived neurogenic ataxia retinitis pigmentosa (NARP) also displayed 
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superoxide-induced apoptosis (Geromel et al. 2001), while complex II deficiency seems to be 
generally linked to apoptotic demise by oxidative damage (reviewed in Grimm, 2013). 
A growing contribution to our understanding of the correlation between defective OPXHOS 
compartments and increased apoptosis comes from increasing numbers of mouse models 
describing mitochondrial mutations. Roughly a decade ago the work of Trifunovic and colleagues 
and in parallel by Kujoth et al underlined the importance of mtDNA integrity in the generation of 
aging-associated degenerations. By generating mice with defective mtDNA-specific polymerase  
proofreading subunits, the authors could demonstrate that accumulating mtDNA mutations 
cause a loss of respiratory chain capacity, severe onset of premature aging and early lethality by 
tissue malfunction due to enhanced apoptosis (Trifunovic et al., 2004; Kujoth et al., 2005). In 
addition, knockout of the mitochondrial transcription factor A (TFAM) revealed massive 
apoptosis in knockout embryos and in the heart of TFAM tissue-specific knockout animals (Wang 
et al., 2001). 
Furthermore, mouse models of defective respiratory chain subunits and assembly factors have 
highlighted the importance of OXPHOS integrity: Enhanced apoptosis preceding fatal 
hepatopathy was demonstrated in mice with a liver-specific knockout of COX10, an 
indispensable assembly factor of the prosthetic heme a of complex IV (Diaz et al., 2008). A 
muscle-specific knockout of COX10 revealed premature aging characteristics like weight loss, 
progressive myopathy and early mortality (Diaz et al., 2005). Embryonic lethality and early 
mortality was also linked to complex IV deficiency by the knockout of assembly factor SURF1 
(Agostino et al., 2003) as well as for a knockout of SDHD, a membrane-anchoring subunit of 
complex II (Piruat et al. 2004). Knockout-mice of the complex I subunit NDUFS4 appeared 
healthy but  developed fatal encephalomyopathy at the age of 5 weeks (Kruse et al. 2008). 
Aim of the study 
Apoptosis is a vital process in cell homeostasis and tissue-regeneration and has constantly been 
shown to be manipulated by diverse mitochondrial dysfunctions. Even though numerous findings 
in the recent years have shed light on the correlation between the decline of OXPHOS and the 
increase of cell death by apoptosis in various degenerative and aging-associated diseases 
(Breuer et al. 2013), the exact molecular mechanisms that trigger this mitochondrial 
dysfunction-associated tissue demise remain elusive. 
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Overwhelming generation of reactive oxygen species (ROS) has been long-standing associated 
with defective mitochondrial respiration, though the causality of excessive ROS generation and 
the decline of mitochondrial respiratory activity is still heavily debated. However, oxidative stress 
has often been implicated in the onset of OXPHOS-degenerative states as well as aging and 
aging-associated diseases (Cui et al., 2012). In this context, the present work aims to dissect 
the role of the distinct complexes of the mitochondrial respiratory chain towards oxidative stress 
induced apoptosis and tries to substantiate our understanding of the molecular mechanisms 
underlying OXPHOS-dysfunction induced enhanced apoptosis. 
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Material and Methods 
Cell culture 
Human cell lines Hela (CCL-2, obtained from American Type Culture Collection (ATCC), Rockville, 
MD, USA), Hela Bcl-2 (Kashkar et al.,2005), 143B control and 143BCOX (gift from R. Wiesner, 
Cologne, Germany) as well as adult murine fibroblasts of COX10 knockout mice (gift from C. 
Moraes, Miami, FL, USA) and murine embryonic fibroblasts (MEFs) of Bax and Bak single and 
Bax/Bak double-knockout mice (gift from A. Villunger, Innsbruck, Austria) were cultured in 
Dulbecco’s  modified  Eagle’s  medium (DMEM, Gibco (Life Technologies), Darmstadt, Germany), 
supplemented with 10% fetal calf serum (FCS, Gibco (Life Technologies), Darmstadt, Germany), 
100 µ/ml streptomycin and 100 U/ml penicillin (Biochrom (Merck), Darmstadt, Germany).  
DMEM of 143BCOX, COX10 knockout fibroblasts or mammalian cell lines under conditions of 
chemical suppression of the mitochondrial respiratory chain (RC) was supplemented with 1mM 
sodium pyruvate (Biochrom (Merck), Darmstadt, Germany) and 50µg/ml uridine (Sigma-Aldrich, 
Seelze, Germany). 
Chemicals and reagents 
All chemicals were purchased from Merck (Darmstadt, Germany), Roth (Karlsruhe, Germany) 
and Sigma-Aldrich (Seelze, Germany), unless indicated otherwise. Staurosporine, zLEHD-fmk, 
zIETD-fmk and zVAD-fmk were obtained from Enzo Life Sciences (Lörrach, Germany). Rotenone, 
3-nitropropionic acid (3-NP), antimycin A, KCN, oligomycin, and H2O2 were purchased from 
Sigma-Aldrich (Seelze, Germany). 
Measurement of oxygen consumption 
Measurement of oxygen consumption was performed with a Clark-like oxygen electrode system 
(Hansatech Instruments, Norfolk, UK). 4x106 cells were diluted in Buffer E and placed in a 
water-filled, air-saturated chamber at 37oC. Water-dissolved oxygen was reduced by the 
addition of trace amounts of dithionite (Na2S2O4). Oxygen consumption under conditions of 
chemical inhibition of the respective respiratory chain complexes was recorded, related to total 
cell number and expressed as femtomoles O2 per cell per minute. 
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Table 2.1: Buffers for oxygen consumption 
Buffer E 300 mM Mannitol; 5 mM MgCl2; 10 mM KCl; 10 mM KH2PO4, pH 7.4; 1mg/ml 
bovine serum albumin, fatty acid free 
 
Table 2.2: Respiratory chain-inhibitors and concentrations 
Compound RC-complex  Concentration (half-maximum; 
maximum) 
Rotenone NADH dehydrogenase (Complex I) 50; 100 [nM] 
3-NP Succinate dehydrogenase (Complex II) 1; 2 [mM] 
Antimycin A Cytochrome c reductase (Complex III) 50; 100 [µM] 
KCN Cytochrome c oxidase (Complex IV,COX) 0,5; 1 [mM] 
Oligomycin ATP synthase (Complex V) 0,5; 1 [µM] 
 
DNA constructs and siRNA-mediated knockdown 
For the construction of human ceramide synthase (CerS) GFP fusion proteins, open reading 
frames encoding human ceramide synthase 3 and 6 were amplified by PCR with appropriate 
restriction sites and cloned into pEGFP-N3 vector (Clontech, Saint-Germain-en-Laye, France). 
For the generation of CerS6R131A, site-directed mutagenesis PCR was performed on pEGFP-
CerS6. Cells were transfected with TurboFect transfection reagent (Thermo Scientific, Rockford, 
IL, USA) according  to  manufacturer’s  manual  and  incubated  for  at  least  24h. 
Table 2.3: Primers for DNA constructs 
Construct Primer  (‘5-3’) 
CerS3  forward  (5’-EcoRI) GATCGAATTCATGTTTTGGACGTTTAAAGAATGGTTCTG 
CerS3  reverse  (3’-BamHI) GATCGGATCCATGGCCATGCTGGCCATT 
CerS6  forward  (5’-EcoRI) GATCGAATTCATGGCAGGGATCTTAGCC 
CerS6  reverse  (3’-BamHI) GATCGGATCCATCATCCATGGAGCAGGAGCC 
CerS6R131A sense TTCTGTGAGAGCATGTGGAGATTT 
CerS6R131A anti-sense GGCCGTCAGCGTGCTTGGCTTCTCCTG 
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For siRNA mediated knockdown of human CerS6 as well as murine CerS6 (mCerS6), suitable 
amounts of cells were transfected with 100 pmol/ml siRNA using LipofectamineTM RNAimax 
transfection reagent (Life Technologies, Darmstadt, Germany) and incubated for 48h before 
cytotoxic treatment. All siRNAs were purchased from Eurofins MWG Operon (Ebersberg, 
Germany). 
Table 2.4: siRNAs used in this work 
siRNA Sequence Supplier Reference 
CerS6 5’- AAGGUCUUCACUGCAAUUACATT-3’ Eurofins MWG Operon 
(Ebersberg, Germany) 
Senkal et al, 
2010 
mCerS6 5’- GAGGAGAAACCCAGCACUC-3’ Eurofins MWG Operon 
(Ebersberg, Germany) 
- 
SCR 
(human) 
Allstars Neg. siRNA Qiagen  
(Hilden, Germany) 
- 
SCR 
(murine) 
Allstars Neg. siRNA Qiagen  
(Hilden, Germany) 
- 
 
Cell death 
Cell death was measured by trypan blue exclusion using an automated cell counter (CountessTM, 
Life   Technologies,   Darmstadt,   Germany)   according   to   manufacturer’s   instructions.   In   brief,  
approx. 0.75-1.5x105 cells were seeded in 24-well chambers and incubated under desired 
conditions. Before counting, cells were briefly detached with trypsin and diluted to appropriate 
working concentrations. Cell suspension was then diluted with trypan blue in a ratio of 1:1 (v/v) 
and dead cells were measured. 
Measurement of superoxide formation 
For immunofluorescence analysis of superoxide (O2-) formation, MitoSoxTM Red mitochondrial 
superoxide  kit  (Life  Technologies,  Darmstadt,  Germany)  was  used  according  to  manufacturer’s  
instructions. In brief, 3x105 cells were seeded on sterile glass bottom live cell dishes (Greiner 
Bio-One, Frickenhausen, Germany), incubated with 5 µM MitoSoxTM reagent working solution 
and washed three times with warm HBSS/Ca/Mg buffer (Life Technologies, Darmstadt, 
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Germany). Samples were analyzed with an Olympus Flowview 1000 confocal microscope 
(Olympus, Hamburg, Germany). Additionally, 3x105 Hela cells were incubated with 5 µM 
MitoSoxTM reagent working solution and washed three times with warm HBSS/Ca/Mg buffer and 
analyzed by flow cytometry (BD FACSCaliburTM, BD Biosciences, Heidelberg, Germany). 
Sample preparation and immunoblotting (IB) 
Whole cell lysates were prepared by incubating cell pellets in CHAPS lysis buffer on ice for 20 
min and subsequent centrifugation at 14.000 x g for 20 min at 4oC to recover the supernatant. 
To obtain cytosolic extracts, cells were incubated for 20 min in ice-cold HEP buffer following 
mechanical disruption by repeated passaging (x12-15) through a 26 x G 1/2`` needle, the 
supernatant was recovered after centrifugation at 20.000 x g for 20 min at 4oC. For Western 
blotting, equal amounts of protein, determined by BCA protein assay (Thermo Scientific, 
Rockford, IL, USA) were prepared in 1x Laemmli buffer containing 4% ß-mercaptoethanol, 
separated by SDS-PAGE and transferred onto nitrocellulose membranes (Protran BA85, GE 
Healthcare, Freiburg, Germany). After blocking and appropriate incubation in primary and 
secondary antibodies, protein signals were visualized by enhanced chemiluminescence (ECL; 
Thermo Scientific, Rockford, IL, USA). 
Table 2.5: Primary and secondary antibodies (IB) 
Antibody 
 
Isotope 
 
Supplier 
 
ß-Actin mouse, monoclonal Sigma-Aldrich (Seelze, Germany) 
 
Bak (clone G317-2) mouse, monoclonal BD Bioscience (Heidelberg, 
Germany) 
Bax (human) rabbit, polyclonal BD Bioscience (Heidelberg, 
Germany) 
Bax, active (clone 6A7) mouse, monoclonal BD Bioscience (Heidelberg, 
Germany) 
Bcl-xL (clone 5H46) mouse, monoclonal Cell Signaling (Frankfurt a.M., 
Germany) 
Bcl-2 (human,clone 4D7) mouse, monoclonal BD Bioscience (Heidelberg, 
Germany) 
COXI (clone 1D6E1A8) mouse, monoclonal Mitoscience/Abcam (Cambridge, 
UK) 
Cytochrome C (clone 7H8, 
2C12) 
mouse, monoclonal BD Bioscience (Heidelberg, 
Germany) 
Caspase 3 (clone 8G10) rabbit, monoclonal Cell Signaling (Frankfurt a.M., 
Germany) 
Caspase 9 (human) rabbit, polyclonal Cell Signaling (Frankfurt a.M., 
Germany) 
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Caspase 9 (mouse) rabbit, polyclonal Cell Signaling (Frankfurt a.M., 
Germany) 
Ceramide Synthase 6  mouse, polyclonal Abnova (Heidelberg, Germany) 
 
GAPDH (clone D16H11) rabbit, monoclonal Cell Signaling (Frankfurt a.M., 
Germany) 
Mcl-1  rabbit, polyclonal Cell Signaling (Frankfurt a.M., 
Germany) 
Anti-mouse IgG HRP-linked goat Sigma-Aldrich (Seelze, Germany) 
 
Anti-rabbit IgG HRP-linked goat Sigma-Aldrich (Seelze, Germany) 
 
 
Table 2.6: Buffers for sample preparation and immunoblotting 
Antibody dilution buffer 50 mM Tris, pH 7.6; 150 mM NaCl; 0,1% Tween-20; 5% BSA 
 
Blocking buffer 10 mM Tris-Hcl, pH 7.4-7.6; 150 mM NaCl; 5% milk powder; 2% 
BSA; 0.1% Tween-20 
Blot transfer buffer 25 mM Tris-HCl; 190 mM glycine; 20% methanol 
 
CHAPS lysis buffer 10 mM HEPES, pH 7.4; 150 mM NaCl; 1% CHAPS; protease inhibitor 
HEP buffer 20 mM HEPES, pH 7.5; 10 mM KCl; 1.5 mM MgCl2; 1 mM EDTA; 10 
µM cytochalasin B; 1 mM DTT; protease inhibitor 
Laemmli sample buffer (5x) 0.6 M Tris-HCl, pH 6.8; 144 mM SDS; 25% glycerol; 0.1% 
bromophenol blue; 5% ß-mercaptoethanol 
SDS running buffer 190 mM glycine; 20 mM Tris; 0.1% SDS 
S-PBS 120 mM NaCl; 10 mM NaH2PO4; 30 mM K2HPO4, pH 7.6 
 
Immunoprecipitation (IP) of active Bax 
100 µg of whole cell lysates were brought to a final volume of 500 µl with CHAPS lysis buffer 
containing 150mM KCl and incubated with 2 µg of monoclonal, active Bax- specific antibody 6A7 
over night at 4oC. The antigen-antibody complex was immobilized by the addition of 
GammaBind-G-Sepharose (GE Healthcare, Freiburg, Germany) and subsequent gentle rotation 
for 2h at 4oC. Samples were washed twice with CHAPS/ 150mM KCl and the complexes were 
pelleted by centrifugation at 500 x g for 1 min. The resolved pellet was washed twice with 
CHAPS/ 150 mM KCl and further subjected to SDS-Page and western blotting. 
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Lipid analysis  
Total amount of cellular sphingolipid levels were determined from whole cell homogenates of at 
least 1x106 cells. For ceramide synthase activity measurement, 2,5x106 cells were incubated 
with 2 µM C17-sphinganine (Avanti Polar Lipids, Alabaster, AL, USA) for 2h prior to cell 
homogenization. Lipids were extracted in methanol/chloroform 2:1 (v/v) overnight at 48oC, 
purified and analyzed by Liquid Chromatography coupled to Electrospray Ionization Tandem 
Mass Spectrometry (LC-ESI-MS/MS) by Dr. Susanne Brodesser at the Cecad Lipidomics Facility. 
Activity of neutral and acid sphingomyelinase (n/aSMase) was measured by Katja Krönke-
Wiegmann from crude cytosolic extracts (nSMase) or total cell lysates (aSMase) of at least 3x106 
cells in appropriate buffer using 0.2 µCi/ ml [14C]sphingomyelin (Amersham/ GE Healthcare, 
Freiburg, Germany). The amount of sphingolipid hydrolysis derived phosphorylcholin was 
measured by thin layer chromatography (TLC) and scintillation counting (Zinsser Analytic, 
Frankfurt a.M., Germany) 
Table 2.7: Buffers for lipid analysis 
nSMase sample buffer  20 mM HEPES, pH 7.4; 10 mM MgCL2; 2 mM EDTA; 5 
mM DTT, 0.1 mM Na3VO4; 0.1 mM Na2MoO4; 30 mM 
p-nitrophenylphosphate; 10 mM ß-glycerophosphate; 
750 µM ATP; 1 mM PMSF; 10 µM leupeptin; 10 µM 
pepstatin; 0.2% Triton X-100 
aSMase sample buffer 0.2% Triton X-100 
nSMase activity buffer 20 mM HEPES; 1 mM MgCl2, pH 7.4 
aSMase activity buffer 250 mM sodium acetate; 1 mM EDTA, pH 5.0 
 
Fluorescence microscopy 
For immunofluorescence (IF) analyses of Bax activation and cytochrome c release, 3x105 Hela 
cells were transfected with 1 µg of the particular pEGFP-N3 constructs and incubated for 24h 
before subjection to H2O2 for 4h. Cells were washed twice with PBS, fixed in 3% 
paraformaldehyde and simultaneously permeabilized and blocked with blocking buffer for 30 
min. Cells were incubated with monoclonal active Bax 6A7 antibody over night at 4oC. Cells were 
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washed three times for 10 min with washing buffer and incubated with Alexa FluorTM 647 
secondary antibody for 1h at room temperature. Cells were washed three times with washing 
buffer for 10 min. For staining of cytochrome c, directly Alexa FluorTM 555 labeled cytochrome c 
antibody was utilized according to manufacturer’s instructions. Cells were washed three times 
with washing buffer for 10 min and Dapi was added to the second washing step for nuclei 
staining. Samples were mounted onto cover slides using Mowiol mounting medium and 
examined with a spinning disk confocal microscope (Perkin Elmer, Rodgau, Germany). 
Table 2.8: Primary and secondary antibodies (IF) 
Antibody/Compound Isotope Supplier 
Cytochrome C Alexa FluorTM 555  mouse, monoclonal BD Bioscience (Heidelberg, Germany) 
Anti-mouse Alexa FluorTM 647 goat Life Technologies (Darmstadt, Germany) 
Dapi - Life Technologies (Darmstadt, Germany) 
 
Statistical Analysis 
Data are presented as mean of at least three independent experiments. Standard deviation (SD) 
and standard error of the mean (SEM) were calculated as indicated in the figures. Statistical 
significance  was  calculated  by  two  tailed  unpaired  student’s  t-test. 
Software 
Vector NTI    (Plasmids) 
FlowJo     (Flow cytometry) 
Photoshop CS2   (IF, IB) 
ImageJ, Volocity   (IF) 
Illustrator CS2    (data processing) 
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Results 
Chemical inhibition of cytochrome c oxidase selectively enhances ROS-induced cell 
death  
The decline of mitochondrial respiratory capacity and the incidence of cellular death resulting in 
tissue degeneration have been extensively described (Breuer et al. 2013). However, it is still 
unclear how excessive apoptosis within a degenerative tissue impacts on tissue damage caused 
by mitochondrial dysfunction. To investigate how specific alterations of the mitochondrial 
respiratory chain (RC) as well as ATP-synthase impact on apoptosis, the activity of each of the 
five oxidative phosphorylation (OXPHOS) complexes was chemically inhibited in Hela cells 
(Figure 3.1). Oxygen consumption was monitored as a read-out for the efficacy of the chemical 
inhibition of OXPHOS complexes, revealing a reduction in respiration between 15 and 24% of 
untreated conditions (Figure 3.1 B). Inhibitor concentrations were chosen based on maximal 
efficacy without cytotoxic side effects in a period of 48h as measured by trypan blue exclusion 
assay (Figure 3.1 A). 
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Figure 3.1 | Chemical inhibition of mitochondrial respiratory chain complexes 
(A) Hela cells were incubated with increasing concentrations of the respective OXPHOS inhibitors and cell 
death was assessed after 48h by trypan blue exclusion. Error bars represent mean ± SEM (n=3). 
(B) Hela cells were incubated with two concentrations of specific inhibitors as listed in the table and 
oxygen consumption rate was instantly measured with a Clark-like oxygen electrode system. EtOH 
(vehicle) concentration was 1 and 2% (v/v), respectively. Error bars represent mean ± SEM of at least 
four experiments. 
Oxidative damage within an aging tissue (e.g. by mitochondrial dysfunction) has been 
considered as one of the central mechanisms causing tissue degeneration (Turrens, 2003; 
Balaban et al., 2005; Sena & Chandel, 2012). Therefore, we first investigated whether the 
inhibition of OXPHOS complexes interferes with the susceptibility of cells towards oxidative 
stress by exposing Hela cells to RC inhibitors together with increasing amounts of H2O2 (Figure 
3.2). In striking contrast to the inhibition of all other OXPHOS complexes, inhibition of 
cytochrome c oxidase (COX/complex IV) revealed a dramatic increase in susceptibility to H2O2 in 
a dose dependent manner (Figure 3.2). 
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Figure 3.2 | Inhibition of cytochrome c oxidase enhances H2O2-induced cell death 
Hela cells were left untreated or treated with OXPHOS complex inhibitors; (A) rotenone [100 nM], (B) 3- 
nitropropionic acid [2 mM], (C) antimycin A [100 µM], (D) KCN [1 mM], (E) oligomycin [1 µM]. After 24h, 
cells were subjected to increasing concentrations of H2O2 [0; 50; 150 µM] and cell death was assessed 
after 20h by trypan blue exclusion. Error bars represent mean ± SEM (n=6).Statistical significance was 
measured by two tailed unpaired t-test (including all following figures).  *p<0.05, ***p<0.001 
Importantly, the inhibition of the OXPHOS complexes did not interfere with susceptibility to the 
well-known apoptosis-inducer staurosporine (STS) (Figure 3.3).  
 
 
Figure 3.3 | Inhibition of RC complexes does not influence STS-induced cell death 
Hela cells were left untreated or treated with OXPHOS complex inhibitors; (A) rotenone, (B) 3- 
nitropropionic acid, (C) antimycin A, (D) KCN, (E) oligomycin as described in Figure 3.2. After 24h, cells 
were subjected to increasing concentrations of STS [0; 25; 50 nM] and cell death was assessed after 20h 
by trypan blue exclusion. Error bars represent mean ± SEM (n=3). *p<0.05, **p<0.01 
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Notably, in contrast to H2O2 treatment, inhibition of complex V slightly reduced the cytotoxic 
effect of STS (Figure 3.3 E). Taken together, these data indicate that the selective inhibition of 
COX specifically leads to an increased susceptibility towards oxidative stress.  
Cytochrome c oxidase dysfunction enhances oxidative stress-induced apoptosis 
To test whether the increased susceptibility to oxidative stress upon COX inhibition was due to 
enhanced apoptosis, we measured cell death in the presence of caspase inhibitors (Figure 3.4). 
The efficacy of the caspase inhibitors was examined by analyzing the proteolytic activation of 
the executioner caspase 3 upon treatment with TRAIL or STS (Figure 3.4 B). Whereas the 
inhibition of caspase 8 by zIETD potently inhibited TRAIL-induced caspase 3 processing, the 
exposure to zLEHD, a potent caspase 9 inhibitor, only diminished STS-induced caspase 3-
activation. The exposure of KCN-treated Hela cells to the pan-caspase inhibitor zVAD completely 
abolished susceptibility to H2O2, indicating a central role of caspase activation in oxidative stress-
induced cell death upon COX dysfunction (Figure 3.4 A). In order to elucidate the involvement of 
the extrinsic or the intrinsic apoptotic cascade, the initiator caspases 8 or 9 were specifically 
inhibited (Figure 3.4 A). While the inhibition of caspase 9 by zLEHD efficiently reduced cell death 
in KCN-treated Hela cells upon H2O2 treatment (Figure 3.4 A), the inhibition of caspase 8 by 
zIETD revealed significant, but weak reduction of susceptibility towards oxidative stress. These 
results indicate a pivotal role of the intrinsic apoptotic machinery in this process. 
The central and irreversible event in the intrinsic apoptotic pathway is the release of cytochrome 
c (Cyt c) from the mitochondrial intermembrane space (IMS). Indeed, H2O2–induced cell death 
in KCN-treated Hela cells was accompanied by the release of cytochrome c from mitochondria 
and the processing of caspase 9 (Figure 3.4 C). Mitochondrial outer membrane permeabilization 
(MOMP) and the subsequent release of cytochrome c from the mitochondrial IMS are tightly 
regulated by Bcl-2 proteins. In particular, Bax conformational changes represent an immediate 
early response to apoptotic stress, followed by the insertion of activated Bax into the 
mitochondrial outer membrane and pore formation (Martinou & Youle 2011), and the 
conformational changes allow for the specific detection of active Bax (Hsu & Youle 1998). 
Whereas undetectable in control Hela cells, KCN-treated Hela cells showed Bax-activation upon 
treatment with H2O2 (Figure 3.4, lower panel), further confirming the involvement of the 
mitochondrial apoptotic pathway in COX dysfunction-induced susceptibility to oxidative stress.  
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Figure 3.4 | Inhibition of cytochrome c oxidase accelerates mitochondrial apoptosis in 
response to H2O2 
(A) Hela cells were treated with KCN [1 mM] or left untreated and incubated with caspase 8 inhibitor 
zIETD-fmk [2 µM], caspase 9 inhibitor zLEHD-fmk [2 µM] or caspase family inhibitor zVAD-fmk [20 µM] 
and treated with H2O2 [50 µM] for 20h. Cell death was assessed by trypan blue exclusion. Error bars 
represent mean ± SEM (n=3). **p<0.01, ***p<0.001 
(B) Hela cells were incubated with caspase inhibitor as in (A) and treated with TRAIL [5 µg/ml] or STS 
[100 nM]. After 6h, cleavage of caspase 3 was analyzed in total cell lysates by Western blotting. 
(C) Hela cells were left untreated (-) or treated (+) with KCN [1 mM] 24h before addition of H2O2 [0; 50; 
150 µM]. After 6h, release of cytochrome c was analyzed in cytosolic fractions by Western blot. For 
detection of caspase 9 cleavage, total cell lysates were analyzed after 12h by Western blot. Activated Bax 
was immunoprecipitated and analyzed with corresponding Bax of total cell lysates by Western blot. 
(D) Hela cells were left untreated (-) or treated (+) with KCN [1 mM] for 24h before addition of STS [0; 
25; 50 nM]. After 6h, release of cytochrome c and cleavage of caspase 9 was analyzed in cytosolic 
fractions by Western blot. 
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Consistent with the data shown in Figure 3.3, we could demonstrate that COX-deficiency did not 
influence STS-induced cytochrome c release or the activation of caspase 9 (Figure 3.4 D), 
underlining the specific mode of the COX dysfunction-induced accelerated mitochondrial 
apoptosis in response to oxidative stress. 
Even though the causality of ROS increase, mtDNA damage and RC dysfunction is still debated, 
there is a general consensus that increased ROS mainly arises from defects in complex I and/or 
complex III, while COX is of minor importance (Kwong et al., 2007; Orrenius et al., 2007; Diaz 
et al., 2012). To investigate if the sensitivity of COX-deficient Hela cells to oxidative stress is due 
to elevated basal levels of ROS within mitochondria, we measured the generation of 
mitochondrial superoxide (O2-) in the mitochondrial matrix. No difference to DMSO treated 
control Hela cells could be detected after treatment with KCN, while rotenone, the inhibitor of 
complex I, strongly induced superoxide production as shown by FACS-analysis and microscopic 
imaging (Figure 3.5 C and D). 
 
    
Figure 3.5 | COX does not elevate basal ROS levels 
(A) Hela cells were treated with KCN [1 mM], rotenone [25 nM] or vehicle for 24h or 2h and the 
generation of O2- was visualized with MitoSoxTM Red by flow cytometry. DMSO = 2% (v/v) 
(B) Hela cells were treated with KCN [1 mM], rotenone [25 nM] or vehicle for 2h and the generation of O2- 
was analyzed with MitoSoxTM Red by confocal microscopy. DMSO = 2% (v/v) 
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To further investigate the involvement of the mitochondrial apoptotic pathway in KCN-treated 
Hela cells towards oxidative stress the susceptibility of Bax and/or Bak-deficient murine 
embryonic fibroblasts (MEFs) and Hela cells stably overexpressing anti-apoptotic Bcl-2 (Hela Bcl-
2) was analyzed (Figure 3.6-7). In line with our data summarized in Figure 3.4, the single 
deletion of Bax or Bak or double deletion of Bax/Bak (Figure 3.6 A and C) as well as the 
overexpression of Bcl-2 (Figure 3.7 A) completely diminished the COX dysfunction-induced 
susceptibility to oxidative stress. Congruently, in BB DKO (Figure 3.6 B) and Hela Bcl-2 (Figure 
3.7 B) cells the inhibition of COX did not result in the release of cytochrome c upon treatment 
with H2O2, indicating the involvement of the Bcl-2 protein family in this process. 
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Figure 3.6 | COX dysfunction-induced susceptibility to H2O2 is dependent on pro-apoptotic 
Bax and Bak  
(A) MEF isolated from wild type (BB wt) or Bax/ Bak double knockout (BB DKO) mice were left untreated 
or treated with KCN [200 µM]. After 24h, cells were left untreated (-) or treated (+) with H2O2 [100 µM] 
and cell death was assessed by trypan blue exclusion after 18h. Error bars represent mean ± SEM (n=3).  
(B) MEF isolated from wild type (BB wt) or Bax/ Bak double knockout (BB DKO) mice were left untreated 
(-) or treated (+) with KCN [200 µM] 24h before addition (+) of H2O2 [100 µM]. After 6h, release of 
cytochrome c was analyzed in cytosolic fractions by Western blot. 
(C) MEF isolated from wild type (BB wt), single and double knockout of Bax/ Bak (BB DKO) mice were left 
untreated (-) or treated (+) with KCN [200µM]. After 24h, cells were treated (+) with H2O2 [50 µM] and 
cell death was assessed by trypan blue exclusion after 18h. Error bars represent mean ± SEM (n=3) 
**p<0.01, ***p<0.001 
 
            
Figure 3.7 | Bcl-2 overexpression antagonizes COX dysfunction induced susceptibility to ROS 
(A) Hela or Hela Bcl-2 cells were left untreated or treated with KCN [1 mM]. After 24h cells were left 
untreated (-) or treated (+) with H2O2 [150 µM] and cell death was assessed by trypan blue exclusion 
after 18h. Error bars represent mean ± SEM (n=3). ***p<0.001 
(B) Hela or Hela Bcl-2 cells were left untreated (-) or treated (+) with KCN [1 mM] 24h before addition (+) 
of H2O2 [150 µM]. After 6h, release of cytochrome c was analyzed in cytosolic fractions by Western blot. 
Taken together, our data suggest that COX-deficiency induces apoptotic cell death towards 
oxidative stress. This susceptibility is dependent on the induction of MOMP and regulated by the 
Bcl-2 protein family. 
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mtDNA depletion-derived COX deficiency enhances mitochondrial apoptosis in 
response to oxidative stress. 
The naturally occurring causes for mitochondrial respiratory chain dysfunction are predominantly 
somatic or inherited mutations in the mtDNA and nuclear DNA (Schon et al., 2012). In order to 
substantiate the previous findings we had obtained by chemically inhibiting COX, we 
investigated two cell lines with genetically derived COX-deficiency towards their susceptibility to 
oxidative stress. 
The human osteosarcoma cybrid cell line 143BCOX contains a homoplasmic GA transition at 
position 6930 of the mtDNA, leading to a loss of the last 170 amino acids of cytochrome c 
oxidase subunit I (COXI) and to the disassembly of COX (Bruno et al. 1999). Similar to KCN-
treated Hela cells, the 143BCOX cell line displayed a dramatic susceptibility to H2O2 (Figure 3.8). 
Furthermore, although highly susceptible to oxidative stress, 143BCOX cells were not increasingly 
susceptible to STS (Figure 3.8 B). 
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Figure 3.8 | 143BCOX cybrids display enhanced susceptibility to oxidative stress 
(A & B) 143B and 143BCOX cells were treated with increasing concentrations of (A) H2O2 [0; 100; 250 µM] 
or (B) STS [0; 50; 100 nM] and cell death was assessed by trypan blue exclusion after 20h (H2O2, STS). 
Error bars represent mean ± SEM (n=3). ***p<0.001  
(C) 143B and 143BCOX cells were left untreated or treated with rotenone [25 nM] for 3h as indicated and 
the generation of O2- was analyzed with MitoSoxTM Red by confocal microscopy.  
(D) 143B and 143BCOX cells were left untreated or treated with caspase 8 inhibitor zIETD-fmk [2 µM], 
caspase 9 inhibitor zLEHD-fmk [2 µM] or caspase family inhibitor zVAD-fmk [20 µM] and subjected to 
H2O2 [150 µM] for 18h. Cell death was assessed by trypan blue exclusion. Error bars represent mean ± 
SEM (n=3). ***p<0.001 
(E) 143B and 143BCOX cells were treated with increasing concentrations of H2O2 [0; 100; 300 µM]. After 
6h, release of cytochrome c and activation of caspase 3 was analyzed in cytosolic fractions by Western 
blot.  
Importantly, as already shown in KCN-treated Hela cells, no enhancement of mitochondrial O2- 
generation was detectable in 143BCOX cells, thus excluding that the sensitivity towards H2O2 is 
due to increased basal levels of ROS (Figure 3.8 C). To investigate the role of apoptosis in 
susceptibility of 143BCOX cells towards oxidative stress, we pre-incubated 143BCOX cells with 
caspase inhibitors and analyzed cell death after H2O2 treatment. In line with our previous data of 
KCN-treated Hela cells, caspase inhibition by pan-caspase inhibitor zVAD as well as the inhibition 
of caspase 9 by zIETD completely abolished the enhanced susceptibility of 143BCOX to H2O2 
treatment (Figure 3.8 D). Accordingly, the increased cell death in 143BCOX towards H2O2 was 
accompanied by an accelerated release of cytochrome c from mitochondria into the cytosol and 
the subsequent activation of the executioner caspase 3 (Figure 3.8 E). 
Genomic ablation of COX10 enhances mitochondrial apoptosis in response to 
oxidative stress  
The murine fibroblast cell line COX10-/- was generated by the transfection of skin fibroblasts of 
adult mice containing the floxed exon 6 of the assembly factor COX10 with a pCre-Hygro 
plasmid expressing the P1 Cre recombinase, resulting in the disassembly of the COX holoenzyme 
and complete knockout of COX (Diaz et al., 2005; Diaz et al., 2006). In line with our previous 
data obtained in KCN-treated Hela and 143BCOX cell lines, COX10-/- fibroblasts were highly 
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susceptible to H2O2 (Figure 3.9 A), while no alteration in cell death induced by STS could be 
observed (Figure 3.9 B).  
 
 
Figure 3.9 | COX10-/- cells display enhanced susceptibility to H2O2  
(A & B) COX10FL/FL and COX10-/- cells were treated with increasing concentrations of (A) H2O2 [0; 100; 200 
µM] and (B) STS [0; 50; 100 nM] and cell death was assessed by trypan blue exclusion after 20h (STS) 
and 24h (H2O2), respectively. Error bars represent mean ± SEM (n=4). ***p<0.001 
(C) COX10FL/FL and COX10-/- cells were treated with increasing concentrations of H2O2 [0; 25; 50; 100; 250 
µM]. After 6h, release of cytochrome c from mitochondria was analyzed in cytosolic fractions by Western 
blot (upper panel). For detection of caspase 9 cleavage, COX10FL/FL and COX10-/- cells were treated with 
increasing concentrations of H2O2 [0; 100; 200 µM] for 16h and total lysates were analyzed by Western 
blot (lower panel).* = unspecific band 
(D) COX10FL/FL and COX10-/- cells were left untreated or treated with rotenone [25 nM] for 3h as indicated 
and the generation of O2- was analyzed with MitoSoxTM Red by confocal microscopy. 
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Consistent with our findings (Figure 3.5 B and 3.8 C) and in line with the previous observation 
that neuron-specific COX10 knockout does not induce ROS-dependent tissue damage (Diaz et 
al., 2012), basal levels of O2- were not increased in COX10-/- fibroblasts (Figure 3.9 D). Further 
analyzing the nature of enhanced susceptibility towards oxidative stress revealed that as in KCN-
treated Hela cells or 143BCOX cybrids, cell death in COX10-/- fibroblasts was a result of an 
increased mitochondrial apoptosis as evidenced by the accelerated release of cytochrome c and 
the activation of caspase 9 (Figure 3.9 C). 
In conclusion, our data demonstrate that the COX-deficiency in different cell types consistently 
enhances the mitochondrial apoptotic response specifically towards oxidative stress.  
Sphingolipid metabolism is altered upon COX dysfunction  
Our data conclusively revealed that COX-deficiency enhances the mitochondrial apoptotic 
response to oxidative stress. Oxidative stress-mediated activation of caspase has previously 
been demonstrated to be the result of down-regulation of anti-apoptotic Bcl-2 proteins 
(Moungjaroen et al. 2006).  
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Figure 3.10| Expression patterns of Bcl-2 family members are unaffected by COX dysfunction 
Hela cells were left untreated or treated with KCN [1 mM] for 48h. Expression levels of indicated Bcl-2 
proteins were analyzed from total cell lysates of Hela, 143B and 143BCOX cells by Western blot. 
Thus, we hypothesized that an altered expression patterns of the Bcl-2 protein family members 
in COX-deficient cells is the basis of the increased susceptibility to oxidative stress. However, 
analysis of the main pro- and anti-apoptotic Bcl-2 protein family members in Hela and 143B cells 
revealed only a weak increase in the expression of the anti-apoptotic protein Bcl-2 in 143BCOX 
cells, whereas we could not detect further alterations in the expression pattern of other Bcl-2 
protein family members (Figure 3.10). Especially, as would have been expected, neither were 
anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-xL, Mcl-1) down-, nor pro-apoptotic Bcl-2 proteins (Bax, 
Bak) up-regulated. 
In addition to the Bcl-2 protein family, MOMP can be regulated by modifications of the lipid 
composition of the outer mitochondrial membrane, and previous observations have repeatedly 
been demonstrating that the activation of pro-apoptotic Bax and Bak can be controlled by the 
sphingolipid species ceramide (Siskind et al., 2002; Stiban et al., 2006). Sphingolipids, aside of 
being crucial components of lipid compartments, have been shown to participate in versatile 
cellular functions, amongst others, differentiation, proliferation as well as senescence and 
apoptosis (Hannun & Obeid 2008). To test whether the sphingolipid metabolism and in 
particular ceramide levels are altered in COX deficient cells, we performed mass spectrometry 
analysis of whole cell homogenates. Here, we observed that total levels of the majority of the 
short and long chain ceramides were significantly elevated in all cell lines lacking functional COX 
(Figure 3.11). In this context, especially the accumulation of short-chain ceramide C16:0 in all 
COX-deficient cell lines is striking, since C16:0 ceramides have repeatedly been described to 
induce apoptosis upon versatile stress conditions and to synergistically act with Bax to induce 
MOMP (Ganesan et al., 2010; Lee et al., 2011; Aflaki et al., 2012). 
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Figure 3.11 | Short and long chain ceramides accumulate in cells with defective COX 
Total ceramide content of cells (2x106) was analyzed by mass spectrometry. Hela cells were left untreated 
or treated with KCN [1 mM] for 48h. Error bars represent mean ± SD of 2 analytical replicates of 3 
biological replicates (Hela and 143B) and mean ± SD of 2 analytical replicates of 2 biological replicates 
(COX10), respectively. Measurements were performed by Dr. Susanne Brodesser at the Cecad Lipidomics 
Facility. **p<0.01, ***p<0.001 
Representing the center of sphingolipid metabolism, ceramides also act as precursors for the 
synthesis of sphingomyelins and cerebrosides like glucosylceramide (Mullen et al., 2012). The de 
novo synthesis of sphingolipids is initiated by the conjugation of serine to palmitate and a 
subsequent reduction step, generating dihydrosphingosine. In mammals, six different ceramide 
synthases (CerS1-6) synthesize ceramides from dihydrosphingosines or sphingosines in a side-
chain specific manner, generating dihydroceramides which are immediately desaturated to 
ceramides. Among the ceramide synthases, CerS5 and 6 synthesize the pro-apoptotic C16:0 and 
C18:0 as well as C14:0 ceramides. The redundancy of CerS5 and 6 is still a matter of debate, 
however CerS6 has been shown to be involved in apoptosis while CerS5, albeit also participating 
in mediating apoptosis, rather seems to function in ceramide homeostasis (White-Gilbertson et 
al., 2009; Novgorodov et al., 2011; Hoeferlin et al., 2013). Ceramides can then be reversibly 
converted into sphingomyelins by sphingomyelin synthases or glycosylated by glucosyl or 
galactosyl ceramide synthases (Mullen et al. 2012). The accumulation of ceramides can 
therefore occur for several reasons: 1.) The de novo synthesis by ceramide synthases is 
  Results 
36 
 
enhanced, 2.) ceramide regeneration from sphingomyelins by sphingomyelinases (SMase) at the 
plasma membrane is increased or 3.) ceramides originate from the so called salvage pathway by 
reduction of sphingomyelins and glucosylceramides to sphingosine, which can directly act as 
substrate for ceramide synthases.  
To investigate whether the de novo synthesis of ceramides is enhanced, we adapted a protocol 
to analyze ceramide synthesis in viable cells by mass spectrometry (Siskind et al. 2010) and 
traced the incorporation of exogenous C17:0 dihydrosphingosine in control and COX-deficient cells 
(Figure 3.12).  
     
Figure 3.12 | Ceramide synthesis is increased in COX deficient cells 
(A & B) Incorporation of C17:0 dihydrosphingosine [2 µM] into ceramides after 4h was assessed by mass 
spectrometry of total cell homogenates of at least 2x106 cells. Hela cells were left untreated or treated 
with KCN [1 mM] for 48h. Error bars represent mean ± SD of 2 analytical replicates of 4 biological (143B) 
and 2 biological (COX10) replicates, respectively. Measurements were performed by Dr. Susanne 
Brodesser at the Cecad Lipidomics Facility. *p<0.05, **p<0.01, ***p<0.001 
(C) Representative Western blot detecting expression of CerS6 in Hela cells untreated or treated with KCN 
[1 mM] for 48h, 143B and 143BCOX and COX10FL/FL and COX10-/- cells. 
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Dihydrosphingosine is the physiological substrate to which the specific acyl side-chain is 
attached by corresponding ceramide synthases during de novo synthesis of ceramides. 
Incorporation of C17:0 dihydrosphingosine into short chain ceramides was significantly enhanced 
in COX cybrids and COX10-/- fibroblasts, indicating that ceramide synthesis is increased. 
Accordingly, the analysis of the expression level of the responsible CerS for C16:0 ceramide 
revealed an elevated expression of CerS6 in COX deficient cells (Figure 3.12 C).Apoptosis 
induction by versatile stress inducers including CD95, TRAIL, UV-light or H2O2 has been shown 
to result from increased generation of ceramides by the SMases (Goldkorn et al., 1998; Kashkar 
et al., 2005; Dumitru & Gulbins, 2006). To test whether modifications in the activity of SMases 
could be responsible for the observed increase in total ceramide concentrations in COX-deficient 
cells, we performed SMase activity-assays as described previously (Wiegmann et al., 1994) 
(Figure 3.13).  
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Figure 3.13 | COX dysfunction increases intracellular sphingomyelins and reveals little 
disturbance on glucosylceramide metabolism 
Total sphingomyelin and glucosylceramide concentrations of at least 2x106 cells were analyzed by mass 
spectrometry by Dr. Susanne Brodesser at the Cecad Lipidomics Facility. Neutral and acid SMase activity 
was measured from crude cytosolic extracts (nSMase) or total cell lysates (aSMase) of at least 3x106 cells 
by Katja Krönke-Wiegmann. Hela cells were left untreated or treated with KCN [1 mM] for 48h. Error bars 
represent mean ± SD of 2 analytical replicates of 3 biological replicates (Hela and 143B) and mean ± SD 
of 2 analytical replicates of 2 biological replicates (COX10), respectively. **p<0.01, ***p<0.001 
We could not observe alterations in the activity of neither acid nor neutral sphingomyelinase in 
COX-deficient cells compared to controls (Figure 3.13, middle panel) and the increase in total 
cellular sphingomyelin content indicates that sphingolipid de novo synthesis in general is 
modified (Figure 3.13, left panel). 
Furthermore, in addition to de novo synthesis or sphingomyelin-breakdown, ceramide may 
accumulate by the conversion of glucosylceramides, which normally exist in comparable molar 
amounts within various cell types. However, our analyses of the intracellular levels of 
glucosylceramides revealed no persistent modifications within the different acyl side-chains, thus 
it seems unlikely that enhanced glucosylceramide-breakdown is responsible for the elevated 
cellular ceramide content upon COX dysfunction (Figure 3.13 A-C, right panel). 
Taken together, COX dysfunction leads to the accumulation of pro-apoptotic C16:0 ceramide as a 
result of an increased de novo ceramide synthesis through elevated expression of CerS6. 
Inhibition of ceramide C16:0 de novo synthesis completely rescues COX dysfunctional 
cells from ROS induced apoptosis 
Having demonstrated that the de novo synthesis of ceramide is responsible for the increased 
mitochondrial apoptosis in response to oxidative stress, we hypothesized that the inhibition of 
the enzymatic activity of CerS6 should diminish the increased susceptibility to H2O2 in COX-
deficient cells. Whole ceramide synthase family activity can be inhibited by the mycotoxin 
fumonisin B1 (FB1), which due to its structural similarity acts as a competitive inhibitor of 
sphingosine and dihydrosphingosine for the binding site of the enzymes (Wang et al., 1991). 
Accordingly, pre-treatment of all three COX-deficient cell lines with FB1 significantly reduced cell 
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death and the release of cytochrome c as evidenced in Hela cells upon treatment with H2O2 
(Figure 3.14 A and C).  
 
      
Figure 3.14 | Inhibition of the CerS family by FB1 rescues COX deficient cells from H2O2 
induced apoptosis 
(A & B) Hela cells were treated or left untreated with KCN [1 mM] and FB1 [20 µM]. After 24h cells were 
treated with H2O2 [50 mM] or STS [100nM] and cell death was assessed by trypan blue exclusion after (A) 
20h and release of cytochrome c was analyzed in cytosolic extracts after 6h by Western blot (right panel) 
or (B) 18h. 
(C) 143BCOX cells were left untreated or treated with FB1 [30 µM]. After 24h, cells were treated with H2O2 
[250 µM] and cell death was assessed by trypan blue exclusion after 16h (left panel). COX10-/- cells were 
left untreated or treated with FB1 [50 µM]. After 24h, cells were treated with H2O2 [100 µM] and cell 
death was assessed by trypan blue exclusion after 20h (right panel). **p<0.01, ***p<0.001 
Additionally, STS-induced apoptosis was unaffected by the inhibition of ceramide synthases, 
further underlining the specific role of ceramides in conducting COX-deficiency induced 
apoptosis to oxidative stress (Figure 3.14 B). More specifically, an siRNA mediated specific 
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knockdown of CerS6 resulted in a reduction of cell death in all COX-deficient cell lines (Figure 
3.15 A, C and E), and knockdown of CerS6 was sufficient to block the release of cytochrome c 
and activation of caspase 9, highlighting the central role of CerS6 in COX-deficiency mediated 
susceptibility to oxidative stress (Figure 3.15 B and D). 
  
Figure 3.15 | siRNA mediated knockdown of CerS6 abrogates H2O2 induced apoptosis in COX 
deficient cells 
(A) Hela cells were transfected with siScr [25 nM] or increasing concentrations of CerS6 specific siRNA 
[25, 50, 75 nM] and knockdown of CerS6 was assessed after 72h by Western blot (left panel). Hela cells 
were either transfected with siScr [25nM] or siCerS6 [50 nM]; after 24h, cells were left untreated or 
treated with KCN [1 mM]. After 48h, cells were treated with H2O2 [50 µM] and cell death was assessed by 
trypan blue exclusion after 20h (right panel). 
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(B) Hela cells were treated as in (A). After 48h cells were treated with increasing concentrations of H2O2 
[0, 50, 150 µM] and release of cytochrome c was analyzed in cytosolic fractions after 6h by Western blot. 
For detection of caspase 9 cleavage, total cell lysates were analyzed after 12h by Western blot  
(C) 143B cells were treated with siScr and siCerS6 as in (A) and knockdown of CerS6 was assessed after 
72h by Western blot (left panel). 143B cells were either transfected with siScr [25nM] or siCerS6 [50 nM]; 
after 48h cells were treated with H2O2 [150 µM] and cell death was assessed by trypan blue exclusion 
after 20h (right panel). 
(D) 143B cells were treated with siScr and siCerS6 as in (A). After 48h cells were treated with increasing 
concentrations of H2O2 [0, 150, 300 µM] and release of cytochrome c and cleavage of caspase 9 was 
analyzed in cytosolic fractions after 6h by Western blot 
(E) COX10FL/FL cells were transfected with siScr [25 nM] or siCerS6 [25, 75 nM] and knockdown of CerS6 
was assessed after 48h by Western blot (left panel). COX10 cells were either transfected with siScr [25 
nM] or siCerS6 [75 nM]; after 24h cells were treated with H2O2 [300 µM] and cell death was assessed by 
trypan blue exclusion after 24h (right panel). *p<0.05, ***p<0.001 
Based on these findings, we assumed that the overexpression of CerS6 alone should confer 
susceptibility to H2O2. Therefore, Hela cells were transfected with DNA constructs encoding 
either GFP-tagged CerS6, the enzymatic inactive mutant of CerS6R131A, CerS3 (generating C24 
and C26-ceramides) or GFP alone and subsequently subjected to H2O2 (Figure 3.16). Only 
overexpression of CerS6 resulted in activation of Bax and the release of cytochrome c (Figure 
3.16, second row), while neither the overexpression of the enzymatic inactive CerS6 mutant 
(fifth row) nor CerS3 induced apoptosis (fourth row). 
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Figure 3.16 | Overexpression of CerS6, but not CerS3 or inactive CerS6, induces apoptosis in 
Hela cells treated with H2O2 
Hela cells were transfected with the indicated CerS-GFP constructs or empty vector. After 24h, cells were 
subjected to 200 µM H2O2 for 4h. Cells were fixed and cytochrome c and active Bax were visualized by 
appropriate antibody staining. Images were taken by Saskia Günther. 
Together, these data identify CerS6 as the key mediator of the COX-deficiency induced 
accumulation of pro-apoptotic C16:0 ceramide. 
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Generation of liver-specific COX10 knockout mice on CerS6 knockout and wild type 
background 
Having shown the importance of the COX-deficiency induced accumulation of ceramides in vitro, 
we wanted to investigate the physiological relevance of our findings within a previously 
described mouse model. The liver specific COX knockout mice from the group of Carlos Moraes 
developed severe and fatal hepatopathies (Diaz et al., 2008), while hemizygous Cre expression 
revealed a patchy distribution of COX-deficient and simultaneously apoptotic hepatocytes. 
Interestingly, the liver in these animals fully recovered during lifetime, representing effective 
liver regeneration driven by fully respiring hepatocytes. Having demonstrated that COX-
deficiency induced accumulation of C16:0 ceramide sensitizes towards H2O2-induced apoptosis in 
vitro, we hypothesized that C16:0 ceramide physiologically serves to mediate apoptosis in COX-
deficient hepatocytes and therefore contributes to liver regeneration in vivo. These findings 
prompted us to generate liver specific COX knockout mice on a Lass6 (longevity assurance gene, 
the gene coding for CerS6) deficient background. CerS6 knockout mice were generated by the 
Group of Martin Krönke and Jens Brüning using the Cre-lox recombination technology. These 
mice display no obvious phenotype and develop normally (unpublished results). 
To date, we did not succeed in generating mice homozygous for the floxed COX allele and AFP-
Cre positive on a homozygous CerS6-kbockout background, as exemplified by two independent 
breedings in Figure 3.17. From our statistical analysis, one may conclude that the liver-specific 
knockout of COX is embryonic lethal. However, we also did not receive Cre-positive offspring 
with homozygous floxed COX alleles on heterozygous (Figure 3.17) or wild type CerS6 
background (not shown).  
In summary, despite ongoing breeding, until now we have to conclude that the presumed 
embryonic lethality cannot be attributed to deficiencies in CerS6 expression alone. 
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Figure 3.17 | Breeding of floxed COX10/Lass6-/- mice with floxed COX10/Lass6-/wt AFP(+) 
mice did not generate mice with homozygous knockout of COX 
Initial breeding of AFP-positive mice with COX10FL/FLLass6-/- mice generated mixed offspring of 
COX10FL/wtLass6-/wt mice with an AFP-negative to positive ratio of 5.3:4.7. Backcrossing of AFP-positive 
mice with COX10FL/FLLass6-/- mice did not result in offspring with homozygous floxed COX10 allele, 
reflected by a shift of the AFP negative to positive ratio of 6.5:3.5. 
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Discussion 
Since the first discovery of diseases-causing mutations of nuclear (Bourgeron et al., 1995) and 
mitochondrial DNA (Holt et al., 1988; Wallace et al., 1988) encoded oxidative phosphorylation 
(OXPHOS) proteins, the role of mitochondrial respiratory chain defects in the onset of 
degenerative diseases has been confirmed by tremendous research efforts (Ylikallio & 
Suomalainen 2012). In particular, strong correlations between the decline of mitochondrial 
respiratory capacity and the incidence of cellular death and tissue degeneration have been 
extensively described (Breuer et al. 2013). However, our knowledge about the nature of the 
cellular death process caused by defective mitochondrial respiration remains incomplete.  
In the present work we demonstrate a selective susceptibility of cells with deficient cytochrome 
c oxidase (COX), the terminal complex of the mitochondrial respiratory chain, towards hydrogen 
peroxide (H2O2) treatment. By contrast, the inhibition of all other OXPHOS complexes does not 
induce H2O2 sensitivity. In particular, we observe a significant increase in mitochondrial 
apoptotic signaling in response to H2O2 in COX-deficient cells. Mechanistically we show that 
COX-dysfunction facilitates apoptosis by the accumulation of the pro-apoptotic sphingolipid 
species C16:0 ceramide. The accumulation of ceramides in COX-dysfunctional cells is the result of 
enhanced expression of the respective ceramide synthase (CerS) 6 and increased de novo 
synthesis. The inhibition as well as the knockdown of CerS6 abrogates the COX-dysfunction 
induced susceptibility to H2O2 underscoring the central role of CerS6 in this process. 
Inhibition of COX reveals selective susceptibility to oxidative stress 
How distinct defective respiratory chain complexes contribute towards the induction of cell death 
is currently unknown. Nonetheless the cytotoxic role of reactive oxygen species (ROS) in 
degenerative diseases and aging tissues (Lin & Beal, 2006) is indisputable. But even though the 
nature of ROS-induced cell death has been subject to long-timed debates, whether and how 
oxidative damage induces cell death in degenerative states is not clear. Our present study 
demonstrates that the chemical inhibition of COX but none of the other OXPHOS complexes 
selectively enhances the susceptibility to oxidative stress by H2O2 (Figure 3.2), but not to 
staurosporine (STS). This initial observation was further confirmed using COX-deficient cybrids 
and knockout fibroblast (Figure 3.8 and 3.9). 
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COX-deficiency has been linked to various degenerative diseases affecting single tissues (e.g. 
encephalopathy, myopathy, hepatopathy) or multiple organs (MELAS, LS). In vitro and in vivo 
analyses support the notion that defects in COX promote cell death and fatal tissue demise 
(Diaz, 2010). Moreover, COX-deficiency has been shown to results in enhanced apoptotic cell 
death (Agostino et al., 2003; Baden et al., 2007; Diaz et al., 2008) and in patients with COX-
deficiency, oxidative stress was accompanied by increased apoptosis in myofibers (Di Giovanni 
et al. 2001). However, the underlying molecular mechanisms driving COX-deficiency induced 
apoptosis to oxidative stress remains unclear. In this context, our data clearly demonstrate that 
H2O2 induces apoptosis in COX-deficient cells by initiating the activation of Bax, resulting in the 
permeabilization of the outer mitochondrial membrane (MOMP) and subsequent release of 
cytochrome c into the cytosol and activation of caspases (Figure 3.4, 3.8 and 3.9). MOMP is 
tightly regulated by pro- and anti-apoptotic members of the Bcl-2 family (Youle & Strasser 
2008). Remarkably, the expression profiles of pro- and anti-apoptotic molecules have been 
demonstrated to be altered as a cause of retrograde signaling of defective mitochondria to the 
nucleus (Chandra et al., 2002) and mtDNA depletion-induced resistance to apoptosis is 
suggested to result from the altered expression of Bcl-2 proteins, thus shifting the balance 
towards anti-apoptotic Bcl-2 and Bcl-xL (Biswas et al., 2005). These findings might provide a 
possible explanation of how OXPHOS dysfunction affects the apoptotic fate of cells. By contrast, 
our present study demonstrates that neither the inhibition of COX by KCN nor COX-deficient 
cybrids revealed altered expression profiles of the major anti- and pro-apoptotic Bcl-2 proteins 
that could explain the observed enhanced apoptosis (Figure 3.10). Thus, the observed selective 
sensitivity to apoptosis upon H2O2 treatment is unlikely to be a consequence of misbalanced 
apoptosis sensing by the Bcl-2 family. It rather seems that in contrast to severe depletions of 
mtDNA resulting in a global loss of mitochondrial-encoded proteins, the distinct deficiency of 
COX does not interfere with the cellular orchestration of Bcl-2 proteins. However, Bcl-2 proteins 
are not only transcriptionally, but also post-translationally regulated, and modifications of the 
phosphorylation status of different serine-residues of e.g. Bcl-2, Mcl-1 or Bax have been shown 
to be essential for the induction or inhibition of apoptosis (Ito et al., 1997; Domina et al., 2004; 
Gardai et al., 2004). Thus, COX-deficiency may impact on the post-translational regulation of 
Bcl-2 proteins. Further analyses of the post-translational modification of Bcl-2 proteins in cells 
harboring dysfunctional COX could substantially contribute to our understanding of the role of 
Bcl-2 proteins in COX-deficiency derived degenerative states.  
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Accumulation of ceramides sensitizes COX-deficient cells towards oxidative stress-
induced apoptosis 
Our observations show that COX-deficiency induced de novo generation of ceramides is the key 
component of the apoptotic cell death upon oxidative stress (Figure 3.14-3.16). In particular, we 
show that the inhibition of the synthesis of pro-apoptotic C16:0 ceramide is sufficient to prevent 
apoptosis upon oxidative stress, but upon treatment with STS (Figure 3.14). Of note, we only 
observed a relatively small increase of total ceramide C16:0 in Hela cells treated with COX-
inhibitor KCN (~1.65 fold) compared to total C16:0 ceramide increase in COX cybrids (~3.18 fold) 
and knockout fibroblasts (~2.9 fold) (Figure 3.11). This might reflect the incomplete inhibition of 
COX as indicated by residual rates of respiration revealing approx. 22% of residual O2 
consumption (Figure 3.1), while in contrast, respiration was shown to be completely absent in 
COX cybrids (Kwong et al., 2007) and COX10-/- fibroblasts (Diaz et al., 2006). 
Ceramides were shown to have the immanent capability of inducing transmembrane pores in 
cell free phospholipid bilayers (Siskind & Colombini, 2000) and in isolated mitochondria, capable 
of triggering the release of proteins up to 60kDa in size (Siskind et al., 2002). Accordingly, the 
release of pro-apoptotic intermembrane proteins like cytochrome c (14 kDa) or second 
mitochondrial derived activator of caspases (SMAC, 21 kDa) is assumed to result from ceramide 
pore formation on the outer mitochondrial membrane. However, the majority of experiments 
initially performed on cell free membrane systems and on isolated mitochondria relied on the 
use of the synthetic and water-soluble ceramide-analogs ceramide C2 or C6 ceramide. These 
synthetic analogs differ considerably in their biophysical properties from naturally occurring 
ceramides and are hence inappropriate to reflect physiological components of biological 
membranes.  
In this regard, our data demonstrate that the release of cytochrome c is critically dependent on 
the activation of Bax and Bak in COX-deficient Hela cells (Figure 3.6 and 3.16), suggesting 
further involvement of pro-apoptotic Bcl-2 proteins in conducting C16:0 ceramide induced cell 
death. Within the current model, the release of mitochondrial proteins during apoptosis is the 
consequence of conformational change and subsequent activation of Bax and Bak (Youle & 
Strasser 2008). In support of our data, Bax and C16:0 ceramide have been demonstrated to act 
synergistically in conducting the release of mitochondrial intermembrane space proteins 
(Ganesan et al. 2010). Ganesan et al. demonstrated that in the presence of C16:0 ceramide, the 
induction of MOMP in isolated rat liver mitochondria is enhanced upon incubation with cleaved 
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human Bid (tBid) and recombinant human Bax. The authors propose a model in which 
ceramide-induced membrane pores are distorted by membrane bound active Bax oligomers, 
enlarging the pore by insertion of accessory C16:0 ceramides until the size of its curvature 
matches that of active Bax. In addition, our findings are supported by previous work of our own 
lab demonstrating that Bax activation and the release of mitochondrial intermembrane proteins 
upon UV-C stress (Kashkar et al., 2005) was dependent on the availability of C16:0 ceramides. 
In general, Bax and Bak are described to have redundant functions in apoptotic signaling, 
however a MOMP-independent function of Bak has been suggested recently (Beverly et al. 
2013). In particular, it has been demonstrated that Bak is an indispensable activator for the 
immediate generation of C16:0 ceramides upon stress induction (Siskind et al., 2010). The 
authors demonstrated that Bak knockout fibroblast displayed a significant decrease in ceramide 
accumulation and ceramide synthase activity upon UV-C stress, while the ceramide increase in 
Bax-deficient cells was comparable to wild type cells. In KCN-treated single knockout fibroblasts 
of Bax or Bak, we observed indistinguishable resistance towards H2O2 treatment (Figure 3.6), 
suggesting that the contribution of Bak to C16:0 ceramides triggered apoptosis towards oxidative 
stress in COX-deficient cells is presumably restricted to its known pro-apoptotic features. In line, 
in COX-deficient cells ceramide accumulation preceded cell death and sensitized cells to 
oxidative stress induced apoptosis, whereas in the above-mentioned work by Siskind et al. and 
Beverly et al., ceramide accumulation was the consequence of apoptosis induction. Thus 
different mechanisms might control apoptotic induced and mitochondrial dysfunction-driven 
ceramide synthesis.  
Bax/Bak-mediated MOMP is antagonized by anti-apoptotic Bcl-2 proteins (Tait & Green 2010). 
Congruently, we demonstrate that Bcl-2 overexpression completely inhibited MOMP in response 
to oxidative stress in COX-deficient Hela cells (Figure 3.7). However, as already noted before, 
anti-apoptotic Bcl-2 family members have repeatedly been shown to administrate additional 
functions beyond the inhibition of MOMP. In a work by Sawada and colleagues, transient or 
stable overexpression of Bcl-2 and Bcl-xL rescued rat glioma or human glioblastoma cells from 
etoposide, cisplatin or TNF- induced apoptosis by inhibiting ceramide synthesis of aSMase 
(Sawada et al., 2000), presenting an alternative way of apoptosis inhibition by Bcl-2 proteins. 
However, as already mentioned above, we did not observe changes in the expression of neither 
Bcl-2 nor Bcl-xL in COX-deficient cells (Figure 3.10). However, Ruvolo et al. have shown that 
apoptosis by exogenous ceramides-analogs is accompanied by the activation of a mitochondrial 
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phosphatase of the PP2A family which presumably results in the inhibition of Bcl-2 by 
dephosphorylation of serine 70 (Ruvolo et al., 1999). Vice versa, Kawatani and coworkers have 
demonstrated that transmembrane domain-deleted Bcl-2 is still sufficient to inhibit cytochrome c 
release, but failed to reduce ceramide synthesis (Kawatani et al., 2003). Because Bcl-2 is also 
localized to the endoplasmic reticulum (ER) (Lithgow et al., 1994), these findings suggest that 
even though Bcl-2 expression levels are unaltered in COX-deficient cells, Bcl-2 proteins could be 
involved in the regulation of ceramide synthesis at the ER. 
Ceramide Synthase 6 is the key mediator of oxidative stress-induced apoptosis in 
COX-deficiency 
The synthesis of C16:0 ceramide is exclusively and redundantly performed by CerS5 and 6, the 
only CerSs sharing acyl side-chain preference. It appears that both CerS are selectively 
important under specific physiological conditions, yet their individual contribution towards cell 
death remains inconsistent and seems to be dependent on the type of stress (Mullen et al., 
2012). Here we demonstrate that inhibition of the whole CerS-family is sufficient to selectively 
reduce susceptibility to oxidative stress in COX-deficient cells (Figure 3.14). Moreover, we 
provide strong evidence that CerS6 is responsible for the accelerated apoptosis by 
demonstrating that knockdown rescued COX-deficient and overexpression primed normal 
respiring cells to oxidative stress (Figure 3.15 and 3.16). Taken together, we here identify a so 
far unknown role of de novo C16:0 ceramide synthesis by CerS6 in initiating oxidative stress 
induced apoptosis in COX-deficient cells. 
The observation that the inhibition or absence of COX activity has a direct impact on the de 
novo synthesis of C16:0 ceramides which then in turn results in enhanced apoptotic signaling in 
response to oxidative stress (Figure 3.11-16) raises the question how the dysfunction of an 
inner mitochondrial membrane protein complex can influence an ER/MAM-residing enzyme. So 
far only little research has been performed in this regard. However a couple of publications 
highlighted that C16:0 ceramide could actively block COX-activity (Di Paola et al., 2000; Zigdon et 
al., 2013), indicating that infiltration of ceramides is not merely restricted to the outer 
membrane, but might also intrude into the inner mitochondrial membrane. Indeed, ceramide 
incorporation into the inner mitochondrial membrane could be demonstrated (Ardail et al. 2001) 
and ceramides, like cardiolipin, might be able to modify the activity of respiratory chain 
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complexes by protein-lipid interactions. Vice versa, contact sites between the outer and inner 
mitochondrial membrane by the mitochondrial contact site (MICOS) complex localized to cristae 
junctions has been shown to be critical for accurate mitochondrial function and biogenesis 
(Harner et al. 2011). Though no respiratory chain complexes could be located to MICOS under 
physiological conditions, this observation theoretically enables the possibility that other large 
protein complexes, like respiratory chain complexes, might associate to the outer membrane of 
dysfunctional mitochondria. Strikingly, COX has been described to be associated with porins in 
the outer mitochondrial membrane (La Piana et al., 2005) and COX and C16:0 ceramid were 
shown to create contact sites at the outer mitochondrial membrane (Gorgoglione et al. 2010). 
Accumulation of total C16:0 ceramide in COX-deficient cells could be attributed to increased 
expression of CerS6 (Figure 3.11), indicating that COX-deficiency is sensed by a yet unknown 
mechanism(s) resulting in the up-regulation of CerS6. Ceramide accumulation by genotoxic 
stress or -irradiation has initially been revealed to be controlled in a p53-dependent manner 
(Dbaibo et al. 1998) and more recently, p53 was identified to directly induce de novo ceramide 
synthesis by transcriptionally up-regulating CerS5 in leukemia cells upon y-irradiation (Panjarian 
et al. 2008). Accordingly, CerS6 has lately been shown to be a transcriptional target of p53 upon 
folate withdrawal, resulting in increased levels of CerS6 and apoptosis (Hoeferlin et al., 2013). 
Additionally, the activity of p53 itself has been shown to be modified by distinct mitochondrial 
respiratory chain defects (Compton et al. 2011), and p53 is assumed to be responsible for the 
metabolic switch of respiration to enhanced glycolysis in cancer cells by the regulated 
expression of synthesis of cytochrome c oxidase (SCO2) (Matoba et al. 2006; Wanka et al. 
2012). Though the role of p53 in regulating respiratory chain activity is complex and solid data 
concerning its function towards defective mitochondrial respiration is scarce, it seems possible 
that COX-deficiency induces the up-regulation of CerS6 by p53 to efficiently sense malfunctioned 
cells to apoptosis. 
Remarkably, CerS6 has been readily described as a pro-apoptotic protein and is assumed to be 
involved in the induction of mitochondrial apoptosis (White-Gilbertson et al., 2009; Novgorodov 
et al., 2011). CerS6, like all ceramide synthases, has been shown to be localized to the ER 
(Venkataraman et al., 2002; Riebeling et al., 2003; Mizutani et al., 2005; Laviad et al., 2008) 
and compelling unpublished data by our own group analyzing the subcellular localization of all 
CerS strongly support previous findings. However, the mechanism of how CerS6 initiates the 
release of mitochondrial intermembrane proteins remains elusive. Like many enzymes of the 
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lipid metabolism, CerS are hydrophobic membrane proteins and ceramides are likewise 
hydrophobic, neutral molecules restricted to their compartments of formation. Trafficking of 
ceramides from the ER to the Golgi network is executed by ceramide transfer protein (CERT) in 
a non-vesicular manner, and membrane contact sites of both compartments are assumed to 
contribute to efficient ceramide translocation (Hanada et al., 2007). So far, there is no evidence 
for carrier protein shuttling of ceramides from ER to mitochondria. However, ER and 
mitochondria are not only connected by physiological means, but are also in close spatial 
interaction (de Brito & Scorrano 2008; Friedman et al. 2011; Csordás et al. 2006), presumably 
close enough to allow direct translocation of ceramides from the ER-membrane to the 
mitochondrial outer membrane. Strikingly, ceramides were shown to readily flip between 
adjacent membrane compartments (López-Montero et al. 2005) and CerS5 and 6 were found in 
mitochondria associated membranes (MAMs). MAMs are ER-derived membrane compartments in 
close proximity to mitochondria and have been shown to harbor fundamental components of the 
lipid metabolism (Vance, 1990; Raturi & Simmen, 2013). Further, the close proximity is assumed 
to be crucial for the induction of apoptosis by C16:0 ceramide, and it seems possible that ER and 
mitochondria in close juxtaposition facilitate a surrounding in which hydrophobic lipids are 
shared by both membrane compartments. Accordingly, it has been demonstrated that ceramides 
are translocated from MAMs to mitochondria by vesicular transport (Stiban et al., 2008).  
Physiological relevance 
Apoptosis as the physiological cell death is an essential component of cellular homeostasis and 
tissue regeneration (Bergmann & Steller 2010). While reduced apoptosis has been shown to be 
a prerequisite for the formation of cancer (Hanahan & Weinberg 2011), excessive apoptosis is 
assumed to precipitate degenerative states and is implicated in aging and aging-associated 
diseases (Dean, 2008; Breuer et al., 2013). However, it remains controversial whether excessive 
apoptosis is merely detrimental or beneficial in an aging tissue progressively exposed to stress 
conditions. Accordingly, potential benefits of inhibiting apoptosis has been anticipated in 
degenerative  diseases  including  Alzheimer’s  disease  (Dickson 2004; Rohn 2010). 
Based on our incomplete knowledge about the mode of cellular demise within an aging tissue 
and the lack of molecular insights about the crosstalk of degenerative alterations and the 
cellular death machinery, research has been hampered to comprehensively prove the role of cell 
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death in degenerative and aging-associated diseases as well as its regulation in tissue 
regeneration. In liver, alteration of OXPHOS leads to mitochondrial hepatopathy, which rapidly 
progresses to liver failure in some patients. Alternatively, liver pathology may spontaneously 
reverse without manifestation of severe disease. Similarly, in the afore-mentioned mitochondrial 
hepatopathy mouse model created by liver-specific ablation of COX10 gene, some mice showed 
severe COX-deficiency and early liver pathology, but had a complete reversion of all pathological 
phenotypes resulting in a normal mouse life span (Diaz et al. 2008). The continuous 
replacement of damaged hepatocytes and the lack of collateral liver damage upon COX- 
dysfunction indicate the involvement of a controlled hepatocytic demise, which is decisive for 
the coordinated liver regeneration. However, the role and the control of cellular death 
machineries during the course of the pathogenesis of mitochondrial hepatopathy have not been 
elucidated. The present study shows for the first time how mechanistically apoptosis is triggered 
upon COX-dysfunction. Further investigations by employing CerS6-/- or Bcl2tg (blocking 
mitochondrial apoptosis) mice will substantially help us to understand the role of apoptosis in an 
aging tissue. One striking hypothesis would be to induce apoptosis in order to efficiently 
eliminate damaged cells in an aging tissue. This would enable the tissue to regenerate and to 
replace the apoptotic cells. Especially in mtDNA-derived COX-disorders an efficient removal of 
deficient cells with high loads of heteroplasmic mitochondria is crucial to prevent the onset of 
degenerative states, and sensing of COX-deficient cells by C16:0 ceramide accumulation could be 
one possible mode of action. This hypothesis is supported by clinical data: Childhood-onset of 
COX-deficiency derived degeneration disorders like encephalopathy, myopathy, hepatopathy or 
combined encephalomyopathy and encephalohepatopathy are usually severe and fatal at early 
age. However, case reports have repeatedly demonstrated that in some patients, affected 
tissues almost fully recovered within the very first years of age (DiMauro et al., 1983; Nonaka et 
al., 1988; Salo et al., 1992; Zeharia et al., 2009; Schara et al., 2011) and recent work revealed 
that COX levels fully recovered as evidenced by histochemical staining and protein expression 
(Horvath et al. 2009). 
In line with our results concerning the pro-apoptotic role of CerS6 in an aging tissue, 
accumulating recent evidence suggest that silencing CerS6 in cancer promotes drug-resistance 
in a variety of cancer entities including colon, liver, pancreatic and ovarian cancer (Walker et al. 
2009; White-Gilbertson et al. 2009). Together with our findings these observations indicate the 
therapeutic role of CerS in cancer as a regulatory node of apoptosis. 
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In conclusion, our data substantiate previous findings and provide further mechanistic insights 
into how enhanced cell death could contribute to the demise of COX-deficient cells. Our data 
strongly imply that further analyses of the exact molecular crosstalk between COX and CerS6 
might unravel essential aspects of efficient tissue regeneration and could additionally facilitate 
the introduction of potential therapies of COX-deficiency disorders (Figure 4.1). 
 
 
       
Figure 4.1 | Proposed model of COX-deficiency induced apoptosis towards oxidative stress 
COX-deficiency leads by a yet unknown mechanism to enhanced expression of CerS6 and accumulation of 
intracellular C16:0 ceramide, presumably at the ER (1). Upon oxidative stress, C16:0 ceramide translocates to 
mitochondria and induces Bax and Bak dependent permeabilization of the outer mitochondrial membrane 
(2). Release of cytochrome c from the mitochondrial intermembrane space induces the activation of 
initiator-caspase 9 and downstream executioner-caspases, finally resulting in apoptosis of the COX-
deficient cell (3).Mt, mitochondria; PM, plasma membrane; RC, respiratory chain. 
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